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SUMMARY
The effects of insulin, glucagon and other agents on 
rates of lipogenesis and activity of acetyl-CoA 
carboxylase were measured in rat mammary glands during 
lactation ij2 vitro. As a comparison to this, the effect 
of glucagon on rates of lipolysis in rat adipose tissue 
in vitro was investigated at different stages of the 
reproductive cycle.
The rate of lipogenesis in acini isolated from mammary 
glands of mid-1actating rats was studied by measuring 
the rate of incorporation of -3H from into total
lipid and fatty acids, with glucose as a substrate. 
Glucagon did not affect the rate of lipogenesis in rat 
mammary glands in_ vi tro in the presence or absence of 
agents which modulate its effects on adipocytes.
Glucagon did not antagonize the maximal stimulatory 
effect of insulin, nor did it alter the insulin dose- 
response curve. Theophylline, at concentrations up to 
20mM, was a potent inhibitor of lipogenesis in acini. 
Glucagon did not augment the degree of inhibition of 
lipogenesis induced by 5mM-theophy11ine. The results 
suggest that the mammary gland acini do not respond to 
glucagon iri_ vi tro. In agreement with these 
observations, only a minimal degree of specific binding 
of 1=5I-label led glucagon could be detected in acini 
which bound insulin normally. This difference in 
responsiveness of mammary and adipose cell preparations
i
in vitro to glucagon suggests that the two tissues may 
be differentia11y responsive to changes in the 
circulating insulin/glucagon concentration ratio in 
vivo.
Other agents, adenosine and adenosine deaminase were 
found to have no effect on lipogenesis in mammary gland 
acini. Relationships between the cyclic AMP content and 
the rate of lipogenesis in acini prepared from lactating 
rat mammary tissue were investigated by exposing them to 
theophylline which increases their cyclic AMP content in 
the presence or absence of insulin. The dose-dependent 
inhibition of lipogenesis by theophylline in acini 
isolated from fed rats was highly correlated with the 
induced increases in acinar cyclic AMP content. Cyclic 
AMP of acini from 24h-starved lactating rats was more 
sensitive in its response to theophylline than cyclic 
AMP in acini from fed animals.
The activity of acetyl-CoA carboxylase in mammary acini 
was studied under the same conditions as were used for 
the lipogenesis experiments. Insulin and theophylline 
were found to have no effect on the activity of acetyl- 
CoA carboxylase which was in contrast to their effects 
on rates of lipogenesis. Glucagon, adenosine and 
adenosine deaminase had no effect, which supported 
earlier findings.
i i
The do5e-respon5e curves for the effect of insulin on 
lipogenesis in rat mammary gland acini were obtained for 
preparations from lactating animals in different 
physiological and pathological conditions. A much 
closer correlation between changes in acinar rates of 
lipogenesis in_ vitro and mammary lipogenesis in^  vivo 
induced by different physiological states was observed 
than in previous studies. Acini from diabetic and 
starved rats had the lowest rates of lipogenesis.
Cafeteria-feeding did not affect either the basal or 
maximally insulin-stimulated rates. Acini from 
streptozotocin-diabetic rats were most sensitive and 
responsive to insulin, whereas those from early- 
lactating rats were least responsive. In addition, 
lipogenesis in acini from early lactating rats and
Starvation (24h) did not affect insulin sensitivity but, 
after 2h refeeding, insulin sensitivity was 
significantly decreased compared to that in acini from 
normal, fed mid-1actating rats. The results indicated 
that in conditions with low-circulating insulin and low 
rates of lipogenesis, relative to fed animals, the 
response to insulin was greater and the concentration of 
insulin required for the half-maximal response was 
smaller i.e. increased
-fed rats were least sensitive to insulin.
A study of rates of lipolysis in adipocytes from rats 
during pregnancy and lactation was undertaken. 
Incubations were performed in the presence or absence of
sub-maxima11y effective concert trations of adenosine 
deaminase and in the presence of severa 1 concentrations 
of glucagon ( 10-11 to 10-*M). Both the maximal response 
to glucagon and the concentration of the hormone 
required to elicit half-maximal response (EC^-J were 
markedly altered during pregnancy and lactation compared 
to those cells from weight-matched virgin rats. The 
effects of 24h-starvation on these parameters was also 
altered in pregnant and lactating animals. In the fed 
state, the highest g 1ucagon-stimu1 ated rates of 
lipolysis were obtained in adipocytes from mid-1actating 
rats whereas in the starved state the highest rates were 
obtained in cells from pregnant and mid-1actating rats. 
Adipocytes from fed or starved late-pregnant animals had 
EC^ ,., values for glucagon that were several-fold lower 
than those from animals in any of the other 
physiological states studied. By contrast, adipocytes 
from early lactating rats were least responsive and 
least sensitive to glucagon. These changes in 
sensitivity and response of lipolytic rate to glucagon 
in isolated adipocytes correlated with the extent of 
triacy 1 g 1 ycero 1 mobilization from adipose tissue .in. vivo 
as evidenced from changes in mean cell volume of 
adipocytes obtained from animals in different stages of 
the reproductive cycle.
IV
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CHAPTER 1
INTRODUCTION
1
1 LACTATION
1 -1 Physiological Changes
Pregnancy and lactation are physiological conditions 
in which the mother must radically re-align her 
metabolism in order to meet the additional metabolic 
demands made by the offspring. Milk production by 
the mammary gland is the additional metabolic system 
competing for available nutrients with other 
metabolic processes during lactation.
Various physiological changes occur in the mother 
that are geared towards promoting an adequate supply 
of substrates to meet the high metabolic demands of 
the mammary gland. In the rat, at peak lactation 
the food intake is two to three-fold higher than in 
the unmated animal (Fell et aj_. , 1963; Ota &
Yokoyama, 1967; Kumaresan & Turner, 1968; Cripps & 
Williams, 1975) and the cardiac output is increased 
up to two-fold (Chatwin ejt aj^ . , 1969). In addition
to the mammary gland, various organs hypertrophy, in 
particular the liver and alimentary tract, and the 
blood flow to these organs is also increased (Fell 
et al . , 1963; Chatwin et a_l_* » 1969; Craft, 1970;
Smith, 1975; Grigor ejt a_l_. , 1982). In spite of the
increased food intake, lactation is generally 
associated with net depletion of adipose tissue 
reserves, in contrast to the increased accumulation
of lipid observed during pregnancy (Spray, 1950; 
Beaton et. al_. , 1954; Knopp et. a 1 . , 1970; Bershtein &
Aleksandrov, 1977; Flint et al_. , 1979; Sinnet t-Smi th
et a_l_. , 1980; Steingr imsdott i r e_t a_l_. , 1980a;
Naismith ejt al_. i 1982; Oiler do Nascimento & 
Williamson, 1986). This is a major adaptation in 
order to spare substrates such as glucose for the 
mammary gland and to meet the high demand for fatty 
acids required for milk production during lactation.
Biochemical changes, e.g. in the plasma 
concentration of several hormones, accompany these 
physiological adaptations and different tissues 
respond to these endocrine alterations in different 
ways that are discussed later (Vernon, 1989). The 
result of these concerted changes is that during 
lactation lipid reserves in adipose tissue are 
utilised to meet the increasing demands of the 
biosynthesis of milk lipids by the lactating mammary 
gland. Milk fatty acid synthesis in the mammary 
gland is further supplemented by other substrates 
available in the circulation derived endogenously 
and from the diet (Williamson, 1973; Vernon & Flint,
1983). Hence there is a fundamental re-direction of 
lipid metabolism during lactation, the mammary gland 
becoming a major site both of lipogenesis de novo 
and of the uptake and utilisation of plasma 
triacylg1ycero1 fatty acids from lipoproteins 
(Williamson, 1986).
3
.1.2 Fate of Dietary Components
In fed lactating rats the main substrates taken up 
by the mammary gland are glucose and 
triacy1g 1ycerol-fatty acids, the triacylglycerol 
being available in very low density lipoproteins 
(VLDL) and chylomicrons. Several studies have shown 
that plasma glucose is the precursor for the 
synthesis of lactose (Wilde and Kuhn, 1979) and for 
a large proportion of milk lipids (□'Hea & Leveille, 
1969; Kuhn, 1978). However the substrate 
requirements for the lactating ruminant mammary 
gland are different because of their distinctive 
diet and digestive physiology. Glucose, in 
lactating ruminants, is not as important a precursor 
of milk lipids in the mammary gland as it is in 
lactating rats, with acetate and, to a lesser 
extent, |3-hydroxybutyrate being the main precursors 
of milk lipids (Balmain et a_^ . , 1952; Linzell et.
al . , 1972; Bickerstaffe et a_l_. , 1974; Moore &
Christie, 1979). Glucose, due to its limited 
availability in the ruminant, is primarily a 
precursor for lactose synthesis, the glycerol moiety 
of milk lipids and the generation of reducing 
equivalents for lipogenesis (Hardwick et. al_. , 1963;
Bickerstaffe ejt a_l_* * 1974).
A number of potential rate— 1imiting steps in the 
pathway from glucose to fatty acids have been
identified, in particular the activity of acetyl-CoA 
carboxylase and the rate of glucose transport across 
the plasma membrane. Acetyl-CoA carboxylase (EC 
6.4.1.2) catalyses the first step committed to fatty 
acid synthesis and is generally believed to be an 
important regulatory enzyme in this pathway in the 
mammary gland (Williamson, 1980; Munday &
Williamson, 1981; Clegg 1988). From parturition to 
peak lactation, an increase in the activity of 
acetyl-CoA carboxylase in the rat mammary gland 
parallels the increased rates of fatty acid 
synthesis (Mackall & Lane, 1977; Agius & Williamson, 
1980; Martyn & Hansen, 1981). At the onset of 
lactation, the amount of acetyl-CoA carboxylase in 
the mammary gland increases and is accompanied by an 
increase in the proportion of acetyl-CoA carboxylase 
in the active state relative to non-1actating rats 
(Mackall & Lane, 1977; McNeillie & Zammit, 1982). 
Acety1-CoA carboxylase is an en zyme subj ec t to 
reversible phosphorylation/dephosphorylation 
mediating activation and inhibition of the enzyme by 
various hormones, but no change in the 
phosphory1 ation state is apparent at the different 
stages of lactation once lactation is established 
(McNeillie & Zammit, 1982). The ratio of 'initial' 
acetyl-CoA carboxylase activity (measured in crude 
extracts with no preincubation) to 'total' acetyl- 
CoA carboxylase activity (measured after 
preincubation with Mg^"1" and citrate) is used as an
index of the state activation of acetyl-CoA 
carboxylase. The ratio of initial to total acetyl - 
CoA carboxylase is a measure of the degree of 
phosphorylation of the enzyme.
Glucose transport, a carrier facilitated process, in 
the mammary gland has been shown to control the 
overall rate of glucose utilisation in the tissue 
and to change in parallel with lipogenesis in 
mammary acini and in. vivo (Threadgold et_ a_l_. , 1982;
Threadgold & Kuhn, 1984). The mechanism of 
regulation of glucose transport in the rat and mouse 
mammary gland may be due to either phosphorylation 
affecting the activity of the transporter or to 
changes in the number of functional transporter 
molecules or the orientation/conformation of the 
transporter within the plasma membrane (Prosser, 
1988).
Because of the importance of glucose and 
triacy1g 1ycero1 for the synthesis of milk 
constituents in the rat mammary gland, the following 
discussion will concentrate on these metabolites, 
and especially on the role of glucose in 
1i pogenesis.
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1.3 Glucose and Fatty Acid Synthesis
1.3.1 Regulation of Glucose Homeostasis
Insulin and glucagon are released directly into the 
portal vein from the f3 and a cells of the endocrine 
pancreas, respectively. In the liver, glucagon 
stimulates rates of g 1ycogeno1ysis and 
g 1uconeogenesis, while insulin causes increases in 
the rates of glycogenesis and lipogenesis. The 
liver is the major organ for the uptake of insulin 
and glucagon in the non-1actating rat and also an 
important site of their degradation, which is 
important not only for the elimination of the 
hormones from the bloodstream, but also for 
determining the insulin/glucagon concentration ratio 
between portal and peripheral blood (Lefebvre & 
Luyckx, 1979; Parman, 1979; Jungermann, 1983).
Variation of the peripheral insulin/glucagon 
concentration ratio can occur as the result of 
changes in several factors; pancreatic hormone 
secretion, change of the hepatic hormone extraction 
or extrahepatic hormone removal (Balks & Jungermann,
1984). A high peripheral insulin/glucagon 
coneentration ratio is considered to indicate a high 
plasma glucose 'status', a low ratio reflecting low 
glucose 'status'. Insulin and 'counter-regulatory' 
hormones (e.g. glucagon, adrenaline, vasopressin) 
affect glucose homeostasis, with insulin stimulating
glucose uptake and utilisation by many peripheral 
tissues. During lactation, the mammary gland has a 
prominent role in determining the circulatory 
insulin concentration, being an important site for 
the uptake of insulin (Jones ejt a_l_. , 1984a). The
mammary gland also becomes the major glucose- 
utilising tissue in the body, with lipogenesis being 
guantitatively the most important pathway in terms 
of glucose utilisation in the gland (Williamson, 
1980). However, fatty acid biosynthesis in the 
lactating mammary gland must be able to respond 
rapidly to changes in the availability of glucose in 
the circulation to maintain the carbohydrate balance 
within the mother. Hence, the rate of mammary gland 
lipogenesis is closely regulated according to the 
dietary status of the rat and is sensitive both to 
the amount of food eaten and the composition of the 
diet.
1.1.3.1.1 Diurnal Variations
During lactation, there is a diurnal variation in 
the rate of food intake of rats which, although 
generally similar to that of virgin rats, shows some 
differences. Mid-1actating rats consume a higher 
proportion (357.) of their diet during the light 
period (Tachi et a 1., 1981; Munday & Williamson,
1983) than do virgin rats (147.) (Kimura et al_. ,
8
1970; Bruckdorfer et a 1. , 1974; Munday & Williamson,
1983). In lactating animals, the peak rate of 
lipogenesis in the liver occurs around mid-dark, 
decreasing to a lower rate around mid-light as 
observed in non-1actating rats; although the diurnal 
variations in hepatic lipogenesis are not very 
marked (Kimura e_t aX. , 1970; Munday & Williamson,
1983). Hepatic glycogen stores are replenished when 
food intake is still high and hepatic lipogenesis is 
declining. The decline in glycogen content 
parallels the decline in food intake. This 
indicates that when food intake is relatively 
decreased, hepatic glycogen plays an important role 
in supplying the demand for carbohydrate i.e. as a 
precursor for lipogenesis (Nowell, 1970; Munday & 
Williamson, 1983). Hence it is not surprising that 
there is no observed diurnal variation (Carrick & 
Kuhn, 1978) in the arterial concentration of glucose 
(4-5mM) (Robinson e_t aj^ . , 1978; Burnol et a_l_* * 1983)
in the lactating rat. A diurnal variation in the 
arterial concentration of insulin (20-40mU/l, 
l-2ng/ml) has been observed in the lactating rat 
with minimum values occurring during daylight hours 
corresponding to lowest dietary intake (Carrick & 
Kuhn, 1978; Munday & Williamson, 1983). A similar 
pattern has been observed for the non-lactating 
female rat and the male rat (Kaul & Berdanier, 1972; 
Bellinger et. a_K , 1975; Balks & Jungermann, 1984).
No such measurement of glucagon concentration has
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been made in the lactating rat, and studies with 
male rats indicate that glucagon is not subject to 
diurnal changes (Balks & Jungermann, 1984). If 
similar diurnal relationships between insulin and 
glucagon exist in lactating rats, then the 
apparently small diurnal variation of insulin 
observed (a decline of 50’/. occurring around midday) 
(Carrick & Kuhn, 1978; Munday & Williamson, 1983) 
would be more significant when considered as the 
insulin/glucagon concentration ratio, and would 
provide a great amplitude of variation in the signal 
bringing about the necessary metabolic changes in 
response to the varying food intake.
A decline in food intake e.g. in the post-absorptive 
period of feeding, leads to a lowering of the 
peripheral insulin/glucagon ratio and to glucose 
sparing by peripheral tissues sensitive to insulin, 
such as mammary gland, in favour of essential 
tissues not sensitive to insulin e.g. brain, in the 
rat (Robinson et. a_l_- , 1978; Burnol et aj, . , 1983) .
Hence lipogenesis in the mammary gland at peak 
lactation also parallels hepatic lipogenesis, and 
peaks just before maximum food intake (Munday & 
Williamson, 1983). Variations in mammary gland 
lipogenesis were much more marked than those 
observed for hepatic lipogenesis, implying that the 
mammary gland is very sensitive to the metabolic 
status of the animal (Munday & Williamson, 1983).
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However, diurnal changes in lactose synthesis do not 
coincide with the peripheral plasma insulin changes, 
despite the close correlation between lactose 
synthesis and food intake. This implies that 
although lactose synthesis is very sensitive to the 
nutritional status of the mother, insulin does not 
appear to be the dominant hormone controlling this 
process (Carrick & Kuhn, 1978). More recent 
evidence suggests the involvement of a 'novel' 
gastrointestina1 peptide (not a known gut peptide) 
which works synergistica11y with insulin, in the 
regulation of glucose uptake in the mammary gland of 
the lactating rat (Page, 1989).
1.1.3.2 Glucose Utilisation
The glucose turnover rate is enhanced by 80*/. in 
mid-1actating rats relative to virgin or 
non-1actating rats. This is due to increased 
glucose production by the liver, increased glucose 
absorption from the gut and glucose utilisation. An 
increase in glucose utilisation is observed at peak 
lactation in the rat and ruminants (Dils & Parker,
1982). In the rat this occurs at low blood glucose 
and plasma insulin concentrations in the peripheral 
circulation (glucose: virgin = 6-7mM, lactating =
4-5mM (Robinson et a 1. , 1978; Burnol et al. , 1983);
insulin: virgin — 50|JU/ml or 2.1ng/ml, lactating =
16-20^iU/ml or lng/ml; (Robinson et_ aj_. , 1978; Flint
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et. a_l . , 1979; Burnol et a_l^. , 1983). Glucose
utilisation depends both on the blood glucose 
concentration and on the ability of tissues to 
absorb glucose (a parameter that is itself partly 
dependent on insulin concentration). The glucose 
metabolic clearance rate (NCR) is an index of the 
capability of tissues to utilise glucose independent 
of blood glucose concentration (Cherrington et. a 1 . , 
1978). The NCR is increased two fold at peak 
lactation, the rise being mainly due to the active 
mammary gland. The enhanced rate of glucose 
utilisation of the mammary gland represents 45‘/. of 
the total glucose utilisation by the lactating rat 
(Davis & Nepham, 1974; Robinson & Williamson, 1977a; 
Jones & Parker, 1978; Burnol e_t a_l_. , 1983). Studies
in the cow and goat show that glucose uptake by the 
mammary gland represents 60*/. of the total glucose 
turnover rate (Dils & Parker, 1982). The use of the 
euglycaemic clamp technique (Burnol et a_l_. , 1983,
1986b, 1987, 1988) has demonstrated an increased
insulin responsiveness of NCR during lactation which 
confirms that glucose metabolism in the mammary 
gland is affected by insulin iri vivo. Neasurement 
of the rate of lipogenesis in. vivo gave direct 
evidence for the insulin responsiveness of the 
mammary gland (Burnol et^  al_. , 1983, 1986b, 1987,
1988). However, despite this evidence of increased 
glucose utilisation by the mammary gland under the 
influence of insulin in vivo, the effects of insulin
12
on glucose metabolism i_n^ v i t ro in the mammary gland 
were debated until relatively recently. These 
studies performed in. v i tro on mammary slices or 
isolated acini of rat mammary gland (Martin & 
Baldwin, 1971b; Robinson & Williamson, 1977a) 
suggested that glucose uptake by the mammary gland 
was not influenced by insulin, whereas insulin 
stimulated the incorporation of glucose into fatty 
acids (Martin & Baldwin, 1971a; Robinson & 
Williamson, 1977a). As plasma insulin is lower in 
lactating rats than in virgin or non-1actating rats, 
it is necessary to reconcile the apparent paradox of 
low plasma insulin being correlated with a high rate 
of glucose metabolism in the mammary gland 
(discussed later in section 1.1.5). Consequently, 
certain dietary and physiological manipulations have 
assisted in elucidating this further.
1.1.3.3 Short-Term Starvation
The response of mammary gland lipogenesis to 
starvation is rapid, since 6h starvation results in 
887. inhibition of lipogenesis (Williamson ejt a 1 . , 
1983; Jones et a_L- , 1984b). Withdrawal of food for
24h, results in a 98’/. inhibition of mammary gland 
lipogenesis which is accompanied by a reduction of 
acetyl-CoA carboxylase activity and a 90-957. 
inhibition in the rate of glucose transport in vivo, 
which is rapidly reversed by refeeding for 2h
13
(Robinson ejt a_l_. , 1978; Robinson & Williamson, 1978;
Agius & Williamson, 1980; Munday & Williamson, 1981, 
1982; McNeillie & Zammit, 1982; Williamson et a 1 . , 
1983; Bussmann e_t a_L- , 1984; Jones e_t al_* » 1984b;
Jones & Williamson, 1984; Threadgold & Kuhn, 1984; 
Mercer & Williamson, 1986; Munday & Hardie, 1986a).
A change in insulin concentration accompanies these 
states, and induction of short-term insu1in-defiency 
by administration of streptozotoe in to fed lactating 
rats results in substantial inhibition of 
lipogenesis and acetyl-CoA carboxylase activity in 
the mammary gland (Robinson & Williamson, 1977a; 
Robinson et al_. , 1978; Munday & Williamson, 1981,
1982; McNeillie & Zammit, 1982). Administration of 
streptozotoe in to 24h-starved rats prior to 
refeeding with chow, prevents activation of mammary 
gland lipogenesis (Robinson e_t a_l^. , 1978; Munday &
Williamson, 1981). This suggests that insulin may 
be a necessary hormone signal during refeeding.
Admin istration of insulin and glucose to 24h-starved 
rats restores glucose transport and the activation 
state of acetyl-CoA carboxylase in_ vivo (Munday & 
Williamson, 1981; Threadgold & Kuhn, 1984), but only 
partially reverses the effects of starvation on 
lipogenesis in vivo, with none of these effects 
being observed in vitro (Robinson & Williamson, 
1977a; Munday & Williamson, 1981). Insulin infusion 
in the absence of refeeding fails to reactivate 
lipogenesis fully in the gland of 24h—starved rats
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(Jones et a 1. , 1984b). These observations imply
that some other systemic factor(s) e.g. a 
gastrointestina1 peptide, and some other inhibitory 
factor, may be responsible for the changes observed 
in vivo (Page, 1989).
More recent experiments with ISh starved/30 min. 
refed lactating rats show that on refeeding, there 
is a peak in the circulating insulin concentration, 
followed by recovery of glucose uptake and, after a 
time lag, by an increase in the lipogenic activity 
in the mammary gland (Bussmann et_ a_l_. , 1984; Mercer
& Williamson, 1986; Page & Kuhn, 1986). The 
presence of a retardant of carbohydrate digestion, 
or refeeding with oral trig1yceride, or limited food 
availability on refeeding, either suppresses 
lipogenesis (i.e. in the former two cases) or 
prevents a prolonged increase (in the latter case) 
in lipogenesis unlike that seen if the animals are 
fed ad^  1 ibiturn after starvation (Bussmann e_t al , 
1984; Mercer & Williamson, 1987, 1988; Page, 1989). 
This implies that the rat mammary gland in the 
lactating rat is highly attuned to the availability 
of dietary carbohydrate and probably the 
gastrointestinal peptide or other as yet unknown 
modulating factors (Mercer & Williamson, 1987, 1988;
Page, 1989). Continued hepatic g1uconeogenesis 
during refeeding is also required to maintain 
stimulation of mammary qland lipogenesis (Williamson
15
fLt #J_* ’ 1^85). Supression of insulin secretion
after the initial surge of insulin abolishes the 
activation of lipogenesis, suggesting that the 
insu1in—sensitivity of the gland may be acutely 
enhanced over this period of refeeding (Mercer & 
Williamson, 1986; Page & Kuhn, 1986).
1.1.4 Triacy1q 1ycerols and Fatty Acid Synthesis
The products of triacy1g 1ycerol digestion in the rat 
are mainly monoacy1g 1ycerols and long chain fatty 
acids, which are re-esterified and incorporated into 
chylomicrons in the intestinal epithelium, to be 
made available in the peripheral venous blood 
supply. Another important source of fatty acids are 
endogenous triacy1g1ycerols secreted from the liver 
as VLDL. Lipoprotein triacy1g 1ycerol can be taken 
up by any tissue, following hydrolysis by 
lipoprotein lipase (EC 3.1.1.34) (Clegg, 1988). The 
resultant fatty acids predominantly enter the cell, 
whereas the glycerol is removed by the circulation 
and metabolised by the liver and kidney.
In the fed non-1actating rat, chylomicron- and 
VLDL-triacylg1ycerol is removed from the circulation 
in part by adipose tissue for storage and is also an 
important site of lipogenesis from glucose 
(Williamson, 1980). During lactation the rate of 
lipogenesis in adipose tissue is considerably
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decreased (Smith, 1973; Robinson edt^ a_l_. , 1978; Flint
gt a_l_. , 1979). Also the activity of lipoprotein
lipase decreases rapidly at parturition and remains 
low throughout lactation (Otway & Robinson, 1968; 
Hamosh ejt aj_* » 1970; Zinder et_ al_. , 1974; Oiler do
Nascimento & Williamson, 1986). Concomitantly the 
rate of lipolysis in adipose tissue from lactating 
rats increases and adipose tissue becomes more 
sensitive to lipolytic stimuli, such as glucagon 
(Smith & Walsh, 1976; Zammit, 1988). The net result 
of these changes is that, in lactation, less glucose 
and triacylglycerol are removed by adipose tissue 
and more non-esterified fatty acids (NEFA) and 
glycerol are released into the bloodstream from 
adipose tissue.
There are reciprocal changes in the activity of 
lipoprotein lipase in mammary gland to those of 
adipose tissue; the lipoprotein lipase activity in 
mammary gland increases rapidly at parturition and 
remains high throughout lactation (Zinder et^  a 1 . ,
1974). In this way, the mammary gland becomes the 
predominant site of utilisation of fatty acids from 
VLDL. The tissue uses these in addition to the NEFA 
made available from adipose tissue to supplement the 
supply of fatty acids required from milk secretion 
(Hawkins & Williamson, 1972). The net result of 
these changes, is the direction of triacy1g 1ycero1
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to the mammary gland and away from the adipose 
tissue.
Although the ruminant generally derives much less 
triacylglycerol from its diet than the rat, 
nevertheless it too depends on its supply of fatty 
acids from adipose tissue and from its diet for its 
source of long-chain fatty acids for the synthesis 
of milk lipids (Tulloh, 1966; Schoefl & French,
1968; West et §!• , 1972; Annison, 1974; Bickerstaffe
et al.. 1974; Smith & Baldwin, 1974; Chilliard et 
a 1 . . 1977, 1978; Moore & Christie, 1979; Vernon e_t 
a_l_. , 1981).
1.1.4.1 High Fat Diets
During lactation, in rats and mice, the proportion 
of fat in the diet does not affect the fat content 
of milk, but the fat composition of the milk 
resembles that of the diet when this is rich in fat 
(Garton, 1963; Coniglio & Bridges, 1966; Farid e_t_ 
a 1 . , 1'978; Grigor & Warren , 1980). High-fat or
'cafeteria' diets (chow plus palatable high energy 
food) given throughout lactation decrease 
lipogenesis in the mammary gland in vivo in both 
mice (Romsos et a1., 1978) and rats (Agius et a1., 
1980; Grigor & Warren, 1980, Munday & Williamson,
1987) and in. vitro (Coniglio & Bridges, 1966; Agius 
et aj_. , 1980; Bussmann et, aj_. , 1984). Decreased
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rates of glucose utilisation and acetyl-CoA 
carboxylase activity in^  vi tro are observed with the 
high fat diets, which correlate with the inhibition 
of lipogenesis in_ vivo (Agius et a_l_. , 1980; Munday
& Hardie, 1986b; Munday & Williamson, 1987). The 
addition of insulin, in_ vivo and in_ vitro, restores 
lipogenesis, the removal of glucose and the activity 
of acetyl-CoA carboxylase to normal values i.e. 
those fed chow only (Agius e_t a_l_. , 1980, 1981;
Munday & Hardie, 1986b; Munday & Williamson, 1987).
An intragastric load of medium or long-chain 
triacylglycerols inhibits lipogenesis in the 
lactating rat mammary gland in_ vivo, long-chain 
triacy1g 1ycerols having the greater effect (Agius & 
Williamson, 1980). This inhibition of rat mammary 
gland lipogenesis is reversed by insulin 
administration in^  vivo (Agius et al_. , 1981).
However glucose utilisation in^  vi tro by mammary 
gland acini from triacy1g 1ycero1-fed rats was normal 
(Agius & Williamson, 1980), in contrast to that 
observed for rats fed a 'cafeteria' diet. In 
ruminants, different long-chain fatty acids produced 
different effects on lipogenesis i.e. some 
stimulated, some inhibited and others had no effect, 
and these fatty acids also promoted incorporation of 
specific fatty acids into triacylglycerols in the 
mammary gland e.g. palmitate stimulates lipogenesis
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and promotes incorporation of butyrate into milk 
lipids (Hansen & Knudsen, 1987a,b).
Short-term starvation in lactating rats resulted in 
a decrease of triglyceride uptake by mammary gland; 
refeeding (2h) ad[ 1 i bi turn restored triglyceride 
uptake in this tissue (Oiler do Nascimento & 
Williamson, 1988). Insu1in-defiency prior refeeding 
did not prevent the restoration of lipid 
accumulation and lipoprotein lipase activity to fed 
values in the mammary gland. This implied that 
lipid accumulation in mammary gland may not be 
affected by changes in plasma insulin concentration 
and is less sensitive to starvation than is 
lipogenesis or lactose synthesis. The activity of 
lipoprotein lipase in the mammary gland may also be 
unresponsive to insulin, or only responsive to much 
lower concentrations of insulin than are required 
for lipoprotein lipase in adipose tissue, thereby 
providing a different regulatory mechanism of this 
enzyme in the two tissues during lactation (Oiler do 
Nascimento & Williamson, 1988). These adaptations 
have the advantage that milk lipid content can still 
be maintained for a short while after withdrawal of 
food.
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• 5 Hormonal Regulation of Mammary Gland and Adipose 
Tissue Metabolism
The regulation of mammary gland and adipose tissue 
metabolism during lactation can be ascribed to 
long-term and short-term effects of hormones.
Chronic regulation of the metabolism of these two 
tissues involves the long-term effects of hormones 
in the development and maintenance of lactation. 
These hormones are involved in the induction of 
enzyme synthesis and are responsible for changes in 
concentrations of these enzymes (total activity) at 
the onset of lactation. Acute regulation of the 
mammary gland involves the short-term effects of 
hormones which bring about changes in the activity 
of pre-existing enzymes in response to e.g. the 
nutritional state of the animal or to short-term 
pathological conditions. Changes in the activity of 
enzymes are brought about by a variety of effects; 
covalent modification e.g. phosphorylation and 
dephosphorylation (Munday & Hardie, 1987), binding 
of an effector molecule(s), or association / 
dissociation of enzyme subunits.
.5.1 Effects of Prolactin
Studies with a variety of species have shown that 
the onset of lactogenesis is dependent on the rise 
in serum prolactin and the fall in serum
Progesterone, in conjunction with a requirement for 
glucocorticoids (Baldwin & Vang, 1974; Kuhn, 1977; 
Cowie et a 1. , 1980). There are species differences
in the minimum requirement to restore or to maintain 
lactation in hypophysectomised animals and in 
culture systems. These experiments, ijn vivo and in 
vi tro with mice and rats, have generally concluded 
that prolactin, cortisol and insulin are all 
important in the induction of enzyme synthesis in 
the mammary gland at the onset of lactation (Baldwin 
& Martin, 1968; Hallowes et_ aX. , 1973; Baldwin & 
Yang, 1974; Topper & Oka, 1974; Topper & Freeman, 
1980). In ruminants, a high prolactin concentration 
is less important once lactation is established 
(Forsyth, 1986). Instead growth hormone has a 
greater role to play in ruminants, yet growth 
hormone is not essential for lactation in rodents 
(Forsyth, 1986; Madon et_ al_. , 1986).
Prolactin is also associated with the longer-term 
control of lipogenic enzyme concentrations in the 
lactating rat mammary gland (Field & Coore, 1976; 
McNeillie & Zammit, 1982). The rat mammary gland is 
known to possess receptors for prolactin, so 
enabling prolactin to exert a direct effect (Flint 
et al., 1981). However, adipose tissue does not 
have such receptors and therefore it has been 
assumed that prolactin exerts an effect indirectly 
(Flint et al., 1981; Vernon & Flint, 1983).
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Conditions in which the circulating concentration of 
prolactin has been decreased, such as administration 
of bromocryptine, an inhibitor of prolactin 
secretion, for 48h, or removal of pups (24h or 48h) 
result in a decrease of lipogenesis and activity of 
lipoprotein lipase in the mammary gland and an 
increase in lipogenesis and lipoprotein lipase in 
adipose tissue, which suggests that prolactin is 
responsible for the changes observed (Robinson & 
Williamson, 1977a; Agius et_ a_l_. , 1979; Flint e_t a 1 . ,
1981; Oiler do Nascimento et a_l_- i 1989). 
Administration of prolactin reverses the effects of 
prolactin-defiency, but it cannot reverse the 
effects of pup removal for 24h or 48h (Agius et. al . . 
1981; Flint et al_. , 1981). The effects of
pro 1actin-deficiency or weaning can be reproduced 
under conditions where there is no change in plasma 
prolactin i.e. complete sealing of teats (24h) with 
continued suckling, but there is an increase in 
plasma insulin (Oiler do Nascimento et a 1. , 1989).
A parallelism between plasma insulin, lipoprotein 
lipase activity and lipid accumulation in adipose 
tissue has been drawn from the above and other 
experiments, which suggests that plasma insulin is 
more important than prolactin in regulating lipid 
deposition in adipose tissue during lactation (Oiler 
do Nascimento §^ t aj_. , 1989).
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1.1.5.2 Insulin Receptors
The numbers of insulin receptors on tissue cells 
change during pregnancy and lactation relative to 
those observed in tissues of virgin animals. Both 
adipocyte and hepatocyte insulin receptor numbers 
increase during pregnancy but decline at 
parturition, and during lactation the number of 
insulin receptors is similar to those of virgin rats 
(Flint e_t al_. , 1979; Flint, 1980). Conversely, the
number of insulin receptors on epithelial cells of 
the mammary gland are increased during lactation 
(Flint, 1982). The sensitivity of the liver to 
insulin is unchanged in the lactating rat, which 
would agree with the unchanged affinities and 
numbers of hepatic receptors observed relative to 
virgin rats (Burnol ejt al_. , 1983). Similarly the
increase in insulin receptor affinities and numbers 
for the mammary gland are as expected for the 
increased sensitivity of the mammary gland during 
lactation (Burnol e_t a 1 . , 1983, 1986b, 1987; Jones
et al., 1984a). The fact that there is no change in
receptor number implies that adipose tissue may be 
insulin resistant and/or that some other factor is 
responsible for the decreased lipogenesis observed.
A post-receptor defect has been indicated, with more 
recent experiments showing that it is a failure of 
the signal-1ransduction system in the plasma 
membrane at steps subseguent to insulin binding to
24
its receptor i.e. a failure to release the insulin 
'mediator" {Walker & Flint, 1903; Vernon & Flint, 
1983; Kilgour & Vernon, 1987, 1988). This could 
account for the decreased ability of adipose tissue 
to respond to insulin during lactation.
1.1.5.3 Regulation of Adipose Tissue
In adipose tissue the relative concentrations and 
activities of enzymes associated with lipogenesis 
are low and hence the tissue does not have the 
potential to respond to such stimulation by insulin 
as demonstrated by the inability of insulin to 
stimulate fatty acid synthesis in adipose tissue in 
vivo CSmith, 1973; Robinson et al., 1970; Agius et 
al . - 1979; Flint ejt al_. , 1979; Sinnett-Smith et al. . . 
1980; Burnol et al., 1983, 1986a,b, 1987; Jones et 
al« 1984a). In addition, there is evidence that 
adipose tissue may also have decreased sensitivity 
to insulin and increased sensitivity to glucagon 
iBurnol et al.« 1983, 1986a,b, 1987; Kilgour & 
Vernon, 1988; Zammit, 1988).
1.1.5-3-1 Lioolvsis and Effects of Adenosine in Adipose 
Tissue
Lipolysis is the predominant pathway in adipose 
tissue during lactation and is favoured by a low 
iimsulin/glucagon ratio; glucagon stimulating
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lipolysis, insulin inhibiting lipolysis. The 
combined effects of a low insulin/glucagon ratio, 
the decreased responsiveness of rat adipose tissue 
to insulin, and increased sensitivity of lipolysis 
to glucagon during lactation should favour high 
nates of triglyceride mobilisation required at peak 
lactation (Zammit, 1988). However the response of 
adipose tissue to the lipolytic effects of 
catecholamines is unchanged during lactation 
(Aitchison et. a_L. , 1982; Vernon et. a_l_. , 1983).
The response of lipolysis in adipose tissue is 
affected by adenosine in_ vi tro and in. v i vo during 
lactation. Adenosine has wide ranging effects on 
several aspects of cell metabolism that can be 
observed both when released by adipose tissue in 
vivo (Fredholm & Sollevi, 1981) and its accumulation 
in the incubation medium with isolated cell 
preparations iji vi tro (Schwabe e^ t a_l_. , 1973). It is
an important effector of adenylate cyclase activity 
and a modulator of the effects of insulin and 
glucagon on tissues that are responsive to these 
hormones (Fernandez & Saggerson, 1978; Lambert &
Jacquemin, 1983).
Two types of adenosine receptor have been described. 
A x sites mediate inhibition of adenylate cyclase in 
all cases and the A2-receptor in most tissues, 
mediates activation of adenylate cyclase (Fain &
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Malbon, 1979; Fain, 1980; Londos et aj_. , 1983). 
However, the rat adipocyte does present a paradox 
with regard to the effects of adenosine, in that 
both occupancy of both the A x and A_> sites depresses 
cyclic AMP accumulation in the intact cell, which in 
turn inhibits lipolysis (Fain, 1973; Fain e_t a 1 . , 
1973; Trost & Stock, 1977).
Adipocytes isolated from lactating rats have an 
increased ability to respond to adenosine, but the 
sensitivity to adenosine is unchanged compared to 
pregnant or virgin rats (Vernon et_ al_. , 1983, 1987;
Zammit, 1988). 24h starvation has no effect on
rates of lipolysis during lactation, but an increase 
in sensitivity is observed. Administration of 
growth hormone can diminish the response to 
adenosine, but is not thought to be important in 
regulating adenosine concentration in^  vivo during 
lactation. The factor(s) responsible for these 
changes is unknown, prolactin having no effect on 
the response of adipocytes to adenosine (Vernon et 
a K  , 1987).
1.1.5.4 Differential Regulation of Mammary and Adipose 
T issue
In adipose tissue, insulin stimulates and glucagon 
inhibits key steps in the pathway of lipogenesis 
from glucose in isolated adipocytes in vitro (Zammit
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& Corstorphine, 1982b; Green 1983). The 
relationships between the effects of glucagon and 
insulin on adipocytes suggest that lipogenesis in 
adipose tissue ijn vivo is very sensitive to changes 
in the circulatory insulin/glucagon ratio (Zammit & 
Corstorphine, 1982b). By analogy, the same effects 
of these hormones might be expected to be observed 
in the mammary gland. The low insulin/glucagon 
ratio in rats at peak lactation (half that of 
virgins) (Robinson ejt aj_. , 1978), would tend to
favour the counter-regu1 atory actions of glucagon 
versus the effects of insulin on a tissue. However, 
if a tissue is insensitive to the effects of 
glucagon and is acutely regulated by changes in 
circulatory insulin, rather than by the 
insulin/glucagon ratio, a mechanism would thereby 
exist enabling the two tissues to be differentia11y 
responsive to the circulatory insulin concentration. 
The rat mammary gland is one such tissue, 
lipogenesis not being inhibited by glucagon vivo
or in isolated acini in. vi tro (Williamson e_t a 1 . , 
1983; Bussmann et a 1 . , 1984; Jones e_t a_l_* , 1984b) .
Hence the increased sensitivity of the mammary gland 
to insulin, in conjunction with a lack of response 
to glucagon would compensate for the low 
insulin/glucagon ratio that favours inhibition of 
lipogenesis in other tissues.
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1.2 HORMONE ACT TON
In this section the action of insulin and glucagon, 
important regulators of mammary gland and adipose 
tissue lipogenesis, are discussed. Discussion has 
been limited to these two hormones because the 
practical work reported in the following chapters 
was concerned exclusively with their action on 
adipose and mammary metabolism.
1.2.1 Glucagon
Glucagon is a polypeptide hormone containing 29 
amino acid residues, which is released from the 
pancreas in response to dietary stimuli. Glucagon 
binds to a specific receptor which is an intrinsic 
glycoprotein located in the plasma membrane. A 
heterogeneous population of glucagon receptors 
expressing high- and 1ow-affini ties is known to 
exist (Rodbell et a_l_. , 1971a,b,c; Sonne et al . . 
1978), which is analogous to adrenaline acting 
through ax- and (3-adrenergic receptors (Lefkowitz et 
al., 1983). It has been suggested that, at least in
the liver, the two classes of receptors act via 
different second messenger systems : high affinity
sub-type via inositol phosphate, low affinity sub- 
type via cyclic AMP (Wakelam et a K > 1986).
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Sub—maximal coneentrations of glucagon added to 
adipocytes, resulting in low receptor occupancies, 
stimulate adenylate cyclase in a dose—dependent 
manner, maximal activation of adenylate cyclase 
occurring at full occupancy of sites (Sonne & 
Gliemann, 1977). This mode of action is known to 
occur via the low affinity sites (Wakelam ejt a 1 . , 
1986).
1.2.1.1 Adenylate Cyclase
Adenylate cyclase, a plasma membrane enzyme located 
on the internal surface, catalyses the formation of 
cyclic AMP and PPt from ATP, and is part of a 
multi-enzyme complex. The enzyme system, which is 
located in the cell membrane, is composed of at 
least three classes of components (see Figure 1.1). 
The glucagon receptor (R) is functionally distinct 
from adenylate cyclase and only couples to it in the 
presence of glucagon (Houslay ejt a_l_. , 1977). At the
inner face of the membrane are the catalytic unit 
(C) and the nucleotide regulatory components (G) of 
adenylate cyclase. The catalytic unit carries out 
the conversion of ATP into cyclic AMP. Each 
G-component contains site(s) for binding GTP and is 
responsible for mediating the effects of GTP and the 
hormones on the activity of C—component. Two types 
of GTP-binding proteins linked to adenylate cyclase 
have been distinguished functionally. One mediates
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Fig. 1.1 Diagrammatic representation of the adenylate cyclase 
system in mammalian cells.
stimulation (termed Ga), the other inhibition (G1) 
of the adenylate cyclase activity (Ross & Gilmann, 
1980; Rodbell, 1980). The overall activity of 
adenylate cyclase is regulated by the relative 
•activities of Gg and G t, which in turn reflect the 
hormone occupancy of the relevant receptors.
Stimulation of adenylate cyclase activity requires 
the stimulatory hormone, e.g. glucagon, low 
concentrations of GTP (10“^M) and an intact 
adenylate cyclase complex. The binding of GTP both 
decreases the affinity of hormones for their 
receptor and synergistica11y amplifies the hormonal 
stimulation of activity. A GTPase associated with 
the catalytic subunit (GC complex) breaks down GTP 
to GDP and Pi and returns the nuc1eotide-receptor 
complex (GR) back to its uncoupled state (Cooper, 
1983; Birnbaumer e_t aj_* » 1985)
1.2.1.2 Cyclic AMP as a Second Messenger
Cyclic AMP is formed from ATP by the action of 
adenylate cyclase. It acts as a second messenger 
for glucagon by binding to an enzyme, a cyclic 
AMP-dependent protein kinase. The cyclic 
AMP-dependent protein kinase consists of regulatory 
(R) and catalytic (C) subunits (Krebs & Beavo, 1979, 
Pall, 1981) forming a tetrametric structure. Each 
R—subunit monomer has two binding sites for cyclic
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AMP as well as a site for binding C—subunits (Corbin 
gt a 1. , 1978; Weber & Hilz, 1979; Builder et a 1. ,
1980). The binding of cyclic AMP causes 
conformational changes in the R-subunit that results 
in its dissociation from and consequent activation 
of the catalytic subunit. This active protein 
catalyses the transfer of the ^-phosphate 
(phosphory1-) group from ATP to esterifiable 
(-hydroxyl) groups on amino acid residues (serine, 
threonine) in proteins. The resulting covalent 
modifications of the protein (i.e. phosphorylation), 
are known to change their biological activity e.g. 
the activation or deactivation of several hormonally 
regulated enzymes.
Termination of the cyclic AMP signal within cells is 
effected by the hydrolysis of the messenger molecule 
to 5'AMP by specific cyclic AMP-phosphodiesterases, 
which are present in multiple forms in most tissues 
(Thompson & Strada, 1978; Beavo et a_l_. , 1982;
Houslay et. al_. , 1983; Houslay, 1986b). Two distinct 
types, which seem the most important in regulating 
cyclic AMP levels, at least in the liver, are a 
'dense—vesic1e ’ phosphodiesterase and a 
piasma-membrane bound phosphodiesterase (52kDa 
protein) (Marchmont et. aj_. , 1981; Heyworth et aj_. ,
1983b; Pyne et ai., 1987, 1989). The 'dense- 
vesic1e ' phosphodiesterase is activated by both 
glucagon and insulin (Loten et a1. , 1978, 1980;
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Heyworth et. aj_. , 1983b; Houslay et. a_K , 1983). The
mechanism whereby glucagon activates this enzyme is 
distinct from that employed by insulin (as yet 
unidentified) and is mediated by cyclic AMP 
(Heyworth ejt aj^ . , 1983b; Wilson e_t al_. , 1983).
Insulin is known to activate the p1asma-membrane 
bound phosphodiesterase by direct tyrosine 
phosphory1 ation in the intact cell. This 
phosphorylation, in turn, converts the enzyme into a 
substrate for cyclic AMP-dependent protein kinase 
(Pyne et aj_» 1989). However, glucagon has no effect 
on the p1asma-membrane bound enzyme, though there is 
evidence that pretreatment of isolated cells with 
glucagon prevents the activation of the enzyme by 
insulin (Heyworth et al_* » 1983b; Wilson et. al . .
1983). A third species of phosphodiesterase, less 
well-defined, has been identified (Heyworth ejt a 1 . ,
1984). It may be the so-called cyclic GMP-activated 
cyclic AMP phosphodiesterase, which can be activated 
by an insu1 in-mediator preparation (Pyne & Houslay,
1988).
Another mechanism of terminating the cyclic AMP 
signal is the inhibition of cyclic AMP-dependent 
protein kinase. This has been demonstrated in 
hepatocytes where insulin decreases the affinity of 
the protein kinase for cyclic AMP, but does not 
alter the concentration of cyclic AMP (Gabbay & 
Lardy, 1984, 1987).
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A long loop feedback system involving mechanisms
which produce and/or down —regu1 at ion
of hormone receptors has been described (Gavin et 
a_l_. , 1974). The actions of these systems results in 
diminished cyclic AMP accumulation after chronic
hormonal stimulation.
1.2.1.3 Calcium Ions and Phospholipid Metabolism as 
Second Messengers
The effects elicited by glucagon binding to the 
high-affinity receptor sites are thought to be 
mediated by an elevation of in trace 11u 1ar calcium 
ion levels, thus facilitating activation of calcium- 
dependent protein kinases (Sistaire et_ al_. , 1985;
Mauget & Claret, 1986). A mechanism whereby 
glucagon might exert such an effect has been 
proposed (Wakelam ejt aJ_. , 1986). There are
documented examples of hormones e.g. vasopressin, 
adrenaline via a± receptors, binding to surface 
receptors in a variety of tissues, which trigger the 
cleavage, by a phospho1ipase C type hydrolytic 
enzyme, of phosphatidyl inositol 4,5-bisphosphate 
(PIP2) into inositol 1,4,5-trisphosphate (IP3) and 
diacylg1ycerol (DAG). A G protein (Gp), which may 
be p21R*s, is thought to link the receptor binding 
to the activation of this phospho1ipase C (Gomperts, 
1983; Berridge & Irvine, 1984; Farese et al_. , 1985;
exposure to hormones, and to further
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Wakelam e_t a_l^. , 1986). IP^ can release Ca"* from
intracellular stores causing a transient increase in 
cytosolic calcium ion levels (Hendrickson & 
Reinertsen, 1971; Buckley & Hawthorne, 1972; Jones & 
Hie he 1 1 , 1975, 1978; Putney et aj_. , 1980; Prpic et 
al_. , 1982; Berridge, 1983; Berridge et. al_. , 1984; 
Berridge & Irvine, 1984; Farese, 1984). Glucagon, 
at physiological concentrations, has been found to 
cause the breakdown of inositol phospholipids and 
the production of inositol phosphates (Wakelam e_t 
a 1., 1986). This effect is considerably smaller 
than the stimulation of inositol phospholipid 
metabolism elicited by vasopressin in hepatocytes 
(Creba et. al_- » 1983; Thomas et, aj_* » 1984). Although 
it is known that ax adrenoreceptors in liver seem to 
produce a disproportionately large physiological 
response in relation to their rather small 
stimulation of inositol phospholipid metabolism 
(Downes & Michel 1, 1985). These effects of glucagon 
are in contrast with earlier findings in rat liver 
that glucagon does not have any effect on Ca3"'- 
independent PIP3 hydrolysis or Ca^-dependent 
phosphatidy1inositol (PI) hydrolysis (Bell &
Majerus, 1980). At present, these experiments with 
glucagon have been done using only liver cells, so 
it is uncertain whether it also exerts this action 
on extrahepatic tissues. Insulin can stimulate 
production of DAG, but not stimulate IP3 metabolism 
in adipocytes and myocytes (Farese, 1984; Farese et
a_l_. , 1985) . The role of DAG generated by insulin is
unknown, although a possible role for DAG as a 
second messenger has been postulated, as it is known 
to activate a protein kinase C that can 
phosphory 1 ate specific proteins (Takai et a_l_. , 1979;
Nishizuka, 1983; Berridge et a_L. , 1984). However a 
role for DAG with respect to this in conjunction 
with glucagon action has not been identified.
There have also been suggestions that glucagon may 
be a precursor of at least one biologically active 
peptide (Mallat et a 1., 1987). Experiments have 
indicated that this peptide has no effect on 
adenylate cyclase, but it can inhibit both the Ca3'*'- 
activated and Mg ^ -de pen den t ATPase activity and Ca3-" 
transport in liver plasma membranes. Further 
studies are needed in this area to ascertain the 
full implications of such peptide in the actions of 
g 1ucagon.
1.2.2 Insulin
Insulin is a small polypeptide protein made up of 
chains (designated A and B) which are held together 
by disulphide bridges. The insulin receptor is a 
glycoprotein and an integral component of the plasma 
membrane, with the carbohydrate portion of the 
receptor located on the external surface of the cell 
(Jacobs et aj_. , 1980a,b). It consists of a
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heterotetramer with two a-subunits and two 
3-subuni ts linked covalently by disulphide bonds.
Insulin can elicit a maximum biological response 
with only a small number of receptors occupied, the
additional 97 — 997. of receptors are termed spare 
receptors (Kono & Barham, 1971; Megyesi et al.,
1975). These are not inactive receptors, as other 
biological responses in these and other cells may 
require greater levels of receptor occupancy (Kono &
Barham, 1973). Receptor occupancy by insulin 
obviously contrasts with that observed for glucagon, 
which does not involve spare receptors.
The mechanism of insulin action is only partly 
understood. At one end of the signalling chain, the 
structure of the insulin receptor is known in 
detail, and at the other end, insulin controls 
cellular metabolism by regulating the
phosphorylation of serine and threonine residues in 
key target enzymes. The molecular events linking 
the occupied receptor to changes in target enzyme 
phosphorylation remain obscure. Several theories 
concerning the mechanism whereby insu1 in —receptor 
mediated activity is elicited, are :
(a) by a membrane-bound insulin-dependent tyrosine 
k inase;
(b) by an inositol phosphate mediator;
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(c) by a insulin-specific guanine nucleotide 
regulatory protein (GIN1S) activated protein 
kinase.
1.2.2.1 Tyrosine Kinase Activity
Receptors for insulin express tyrosine kinase 
activity, acting upon target proteins, the best 
characterised of which is its own (3-chain, in 
lymphocytes and hepatoma cells (Kasuga et aj_. , 1982; 
Petruzelli e_t aj_. * 1982, 1984; Van Obberghen et. a 1 . .
1983). The insulin receptor can phosphory1 ate 
tyrosine residues of exogenous substrates, e.g. 
histone, casein, and is cyclic AMP-independent 
(Petruzelli et al_. , 1982; Kasuga et. al_. , 1983; 
Stadtmauer & Rosen, 1986). The phosphorylation of 
the 52kDa plasma membrane phosphodiesterase by 
insulin in isolated rat hepatocytes is the first 
real evidence of the receptor tyrosyl kinase 
activating directly an enzyme known to be insulin- 
sensitive (Pyne et aj_. , 1989). Whether the receptor
autophosphorylation might be coupled to the 
activation or inactivation of specific protein 
kinases remains to be elucidated. One possibility 
is that the interaction of insulin with its receptor 
stimulates the generation of low molecular weight 
'mediators' which serve as intermediates in the 
signalling process (see section 1.2.2.2). Other 
possibilities of action are to modify the activity
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of a membrane protease which in turn generates a 
second messenger; or to initiate a cascade of 
phosphory 1 ation and dephosphory 1 at ion reactions that 
are responsible for the effects of insulin (Kasuga 
et al., 1982)
1 .2.2.2 'Mediator' as Second Messenger
Originally, these 'mediators' were thought to be 
peptides or complex molecules composed of peptide, 
sugar and lipids (Seals & Czech, 1980, 1981; Larner 
et al . . 1981; Saltiel et al_. , 1981; Kiechle et al . ,
1981). More recent evidence indicates that these 
putative 'mediators’ of insulin action are phospho- 
ol igosaccharides (POS) composed of phosphate, 
inositol, glucosamine and galactose (Mato et. a 1 . , 
1987a,b; Saltiel ejt a_l_. , 1987) Phosphodiesteratic 
hydrolysis of a phosphatidy 1 inositol glycan (PI — 
glycan) by a phosphatidy 1 inosito 1 (PI)-specific
phospho1ipase C generates POS, the polar head group, 
and DAG (Saltiel & Cuatrecasas, 1986; Saltiel et 
al. , 1986; Mato et aj_. , 1787a, 1989). The Pl-glycan
is located at the outer surface of a variety of 
cel Is (adipocytes, hepatocytes) and POS, once 
i'*0 g^ 5 0 cj enters the cel Is by an unknown mechanism 
(Mato et al_. , 1989). Differences in the structure
of POS have been detected in different cells or 
tissues (Alemany et al_. , 1987). Pl-glycan is also
very similar to a Pl-glycan involved in regulating
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^he sttachrnent of proteins to cell membranes (Low et 
a_l_. , 1986; Low, 1987) , but the PI—glycan identified
by Mato et al., (1987a,b) is not thought to have
this role as it does not contain amino acids or 
ethano1 amine residues to anchor the protein to the 
glycolipid (Mato et al_. , 1989).
POS is able to mimic many actions of insulin; it can 
modulate the phosphorylation state of key target 
proteins mediating insulin action (Mato e_t a 1 . . 
1989), and is thought to mediate cyclic AMP- 
dependent and cyclic AMP-independent effects of 
insulin (Alemany e_t aj_. , 1987). Evidence to support
this theory has been demonstrated in cell free 
systems and intact cells. POS can affect the 
activity of many enzymes in a manner similar to 
insulin, such as high-affinity cyclic AMP 
phosphodiesterase and pyruvate dehydrogenase in 
adipocytes (Saltiel et a 1., 1986; Saltiel, 1987), 
adenylate cyclase (Saltiel, 1987), hormone-sensitive 
lipase (Alemany et a_l_. , 1987), and cyclic AMP-
dependent protein kinase (Villalba et a 1., 1988).
POS"also has been demonstrated to have insulin-like 
effects on intact cells e.g. in adipocytes on 
lipolysis and lipogenesis (Kelly et_
Saltiel & Sorbara-Cazan, 1987), and in hepatocytes 
on cyclic AMP levels and lipogenesis (Alvarez et 
al . , 1987; Mato et_ aJN , 1989). However, the
'mediator' is not able to stimulate glucose
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transport (Kelly et_ a_l^. , 1987). However the DAG 
(distinct from that generated by IPT metabolism) 
generated in conjunction with POS, is thought to 
possibly regulate glucose transport (Kelly e_t al., 
Saltiel & Sorbara-Cazan, 1987), and protein 
kinase C activity (Blumberg, 1980) or an analoqous 
protein kinase.
As to what links the action of insulin binding to 
its receptor and the activation of the Pi-specific 
phospho1ipase C is not certain. However, by analogy 
to Gp, a specific G protein that links the insulin 
receptor to its phospholipase has been postulated 
(Houslay e_t al_. , 1986).
1.2.2.3 Guanine Nucleotide Regulatory Protein (G,.^ ) as 
Second Messenger
The insulin receptor is known to interact with, and 
activate, a specific GTP—binding protein called G1Ma 
, similar to ' Ga.' and *GX' that act on adenylate 
cyclase shown diagrammatically in Fig. 1.1 (Heyworth 
et al., 1983a,b; Heyworth & Houslay, 1983b; Houslay
& Heyworth, 1983; Houslay, 1985, 1986a,b). As 
insulin inhibits adenylate cyclase, it was expected 
that it might act via G x. However, recent evidence 
has shown that insulin does not mediate its action 
on adenylate cyclase through G t (Gawler et al_. ,
1988) . G ims thought to have properties that bear
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comparison with the G z identified as mediating 
inhibitory effects of adenylate cyclase, but to be a 
distinct species from G t (Heyworth & Houslay,
1983b). It has been proposed that the effect of 
insulin on liver p1asma-membrane cyclic AMP 
phosphodiesterase and adenylate cyclase is mediated 
by G xnb (Heyworth et a_K , 1983a,b; Heyworth & 
Houslay, 1983b; Houslay & Heyworth, 1983).
3 KEY ENZYMES OF LIPOGENESIS & LIPOLYSIS
Acetyl—CoA carboxylase and hormone-sensitive lipase 
play key roles in the regulation of fatty acid 
synthesis and lipolysis, respectively. The way in 
which the activity of these enzymes is regulated, 
with particular reference to insulin and glucagon, 
is discussed,
3.1 Acetvl-CoA Carboxylase
3.1.1 Alteration in the Concentration of the Enzyme in 
T issues
Alterations in the concentration of acetyl—CoA 
carboxylase in tissues (Allman et, aJL- , 1965; Muto & 
Gibson, 1970) are generally a result of long-term 
changes in the physiological states of the animal 
such as lactation or weaning. A reduction of the 
enzyme content being accompanied by decreased total
activity of the enzyme, an increase resulting in 
increased total activity (McNeillie & Zammit, 1982; 
Sinnet t-Smi t h et a_K , 1982).
1.3.1.2 The Actions of Effector Molecules
Effector molecules are known to regulate 
a 11 osterica 11y acetyl—CoA carboxylase (Miller &
Levy, 1969; Denton et a K  , 1977; Yeh e_t a_l_. , 1981); 
citrate increases the activity of acetyl-CoA 
carboxylase and long-chain acyl-CoA esters inhibit 
the enzyme (Halestrap & Denton, 1974; Lane et al.. 
1979). The protomeric form of acetyl-CoA 
carboxylase is a homodimer which in the presence of 
high concentrations of citrate forms polymers 
(Gregolin e_t a_l_- » 1966; Hardie, 1980; Numa & Tanabe, 
1984; Brownsey & Denton, 1985). The role of 
polymerisation and citrate has been explored in 
adipose tissue and mammary tissue (Borthwick e_t a 1 . ,
1987). In the mammary gland, citrate is needed to 
promote po1ymerisation which supported earlier 
findings (Halestrap & Denton, 1974). The 
phosphorylation of acetyl—CoA carboxylase by cyclic 
AMP-dependent protein kinase results in a decreased 
ability to polymerise in the presence of citrate, 
though some polymerisation does occur (Lee & Kim, 
1978; Lent et al_. , 1978; Swenson & Porter, 1985). 
Exposure of adipose tissue to insulin in the absence 
of citrate resulted in increased po1ymerisation, as
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suggested by Halestrap & Denton, (1974), implying 
that the presence of the effector molecule is not 
required since effects persisted after purification, 
but that the covalent modification e.g. 
phosphory1 at ion, is the most likely cause (Borthwick 
et aj_. , 1987) .
1.3.1.3 Phosphorylation
Changes in the activity and the degree of 
phosphorylation of the enzyme in isolated rat liver 
cells and adipocytes have been demonstrated after 
the exposure of these preparations to various 
hormones (Halestrap & Denton, 1974; Geelen e_t a 1 ■ , 
1978; Brownsey e_t al_. , 1979; Witters e_t al_. , 1979; 
Witters, 1981; Brownsey & Denton, 1982; Holland et 
al ., 1984, 1985). Acetyl-CoA carboxylase is
phosphory1 ated by a variety of protein kinases, 
including cyclic AMP- and Ca2*/ca1modu1in-dependent 
protein kinase, protein kinase C, casein kinase-2 
and AMP-activated protein kinase (Hardie & Guy,
1980; Hardie et al_. , 1986; Haystead et aj_. , 1988;
Haystead & Hardie, 1988; Sim & Hardie, 1988). 
Acetyl-CoA carboxylase from the rat has now been 
completely sequenced ( Lopez—Casi 1 1 as et^  3_1_, 1988)
and 7 major regulatory phosphory1 ation sites have 
been identified (Haystead et a 1_. , 1988; Munday e_t
a 1. , 1988a). However, the actions of protein kinase
C and Ca2+/calmodulin-dependent protein kinase are
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not thought to be important in the regulation of 
acetyl—CoA carboxylase in vivo (Hardie et al , 1986;
Haystead ejt a_l_. , 1988; Haystead & Hardie, 1988). 
Acetyl-CoA carboxylase purified from the rat mammary 
gland (Hardie & Guy, 1980; Munday & Hardie, 1984), 
liver (Tipper & Witters, 1982) or adipose tissue 
(Brownsey et a 1 . , 1981) is reversibly phosphory1 ated 
by cyclic AMP-dependent protein kinase, and until 
recently this phosphory1ation and inactivation was 
thought to occur in hepatocytes and adipocytes in 
response to cyclic AMP-elevating hormones (Witters 
et al . . 1979; Brownsey & Hardie, 1980; Holland et 
al., 1984, 1985). However, more recent studies have 
shown that the increased phosphory1 ation in response 
to glucagon elevation of cyclic AMP causing 
inactivation of acetyl-CoA carboxylase in 
hepatocytes, occurs at the sites phosphory1 a ted by 
AMP-activated protein kinase, not at sites 
phosphory1ated by cyclic AMP-dependent protein 
kinase (Sim & Hardie, 1988). This finding suggests 
that acetyl—CoA carboxylase may not be a substrate 
for cyclic AMP—dependent protein kinase in intact 
cells (Sim & Hardie, 1988; Hardie et. aj_. , 1989). 
Acetyl-CoA carboxylase cannot be phosphory1ated by 
both cyclic AMP-dependent protein kinase and AMP- 
activated protein kinase in the same molecule 
(Munday et aj_. , 1988b). Prior phosphorylation of
acetyl—CoA carboxylase with cyclic AMP-dependent 
protein kinase prevents the inactivation and
phosphorylation normally produced by AMP-activated 
protein kinase (Munday et aj_. , 1988b). The 
physiological significance of the phosphory1 ation by 
cyclic AMP dependent protein kinase in hepatocytes 
is unclear in view of the evidence discussed above.
In adipocytes and hepatocytes, insulin stimulates 
phosphorylation of acetyl-CoA carboxylase at site(s) 
distinct from those phosphory1ated by cyclic AMP- 
dependent protein kinase (Brownsey & Denton, 1982; 
Witters et. a K  , 1983; Holland & Hardie, 1985; 
Haystead & Hardie, 1986a), although phosphorylation 
produces no change in activity (Witters ejt al . ,
1983; Holland & Hardie, 1985; Haystead & Hardie 
1986b). However purification of the enzyme on 
avidin-sepharose could result in the loss of the 
effects of insulin on isolated hepatocytes and 
adipocytes due to the poor binding of the 
polymerised form of the enzyme (Witters et a 1.,
1983, Holland & Hardie, 1985; Borthwick et aj_. ,
1987). It has also been suggested that the activity 
alterations measurable in crude extracts of 
adipocytes after insulin treatment result from the 
interaction with acetyl—CoA carboxylase of a tightly 
bound all osteric mediator (Haystead & Hardie,
1986b). Recent analysis of the site(s)
phosphory1ated on acetyl-CoA carboxylase in response 
to insulin in isolated adipocytes have shown then to 
correspond to the sites phosphory1 ated by casein
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kinase-2 (Haystead e_t al_. , 1988). However it is not
clear as to whether insulin activates either casein 
kinase—2 or a protein kinase with the same 
specificity as casein kinase-2 (Sommercorn e_t al_. , 
1987a; Haystead et a 1. , 1988) . Phosphory1 ation of 
acety1-CoA carboxylase by casein kinase—2 has been 
shown to promote dephosphory1 ation at sites 
phosphorylated by cyclic AMP-dependent protein 
kinase, thus resulting in a secondary effect which 
would lead to the activation of the enzyme 
(Sommercorn e_t al_. , 1987b; Witters e_t a_l_. , 1988).
Increased phosphory1 ation and inactivation of 
acetyl-CoA carboxylase has been demonstrated in 
mammary gland extracts from 24h starved rats and 
insulin-deficient rats (Munday & Hardie, 1986a). A 
novel protein kinase has been described (Carling & 
Hardie, 1986) that may be responsible for 
phosphory1 ation of acetyl—CoA carboxylase; the 
activity of this kinase is stimulated by AMP and 
appears to have properties similar to AMP—activated 
protein kinase (Carling et a 1.i 1987). This mammary 
gland kinase may mediate the effects of 24h— 
starvation or high-fat feeding upon acetyl-CoA 
carboxylase in the lactating rat mammary gland.
1.3.1.4 Dephosphorylation
Dephosphorylation of acetyl-CoA carboxylase occurs 
by the hydrolytic cleavage of phosphoryl residues
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under the direction of several protein phosphatases 
differing in their specificities. The most 
significant phosphatases for which acetyl-CoA 
carboxylase is a substrate are protein 
phosphatases-1 , 2A and 2C (Ingebritsen et §!• , 
1983). All three have been shown to reverse the 
phosphory1 ation induced by cyclic AMP-dependent 
protein kinase and lead to the activation of 
acetyl-CoA carboxylase in rat liver, rat mammary 
gland and rabbit mammary gland (Hardie & Guy, 1980; 
McNeillie et a^. , 1981; Tippers & Witters, 1982; 
Ingebritsen & Cohen, 1983; Munday & Hardie, 1984). 
The exposure of acetyl-CoA carboxylase, which has 
previously been activated or inhibited, and 
phosphory1 ated by a hormone, to an antagonistic 
hormone, not only results in the phosphory1 ation of 
its site, but also results in making the 
antagonistic site more susceptible to phosphatase 
action and thereby becoming dephosphory1ated.
Insulin has been shown to stimulate protein 
phosphatase activity in cultured mouse cells and 
that this activity could be attributed to a type-1 
phosphatase (Chan et a 1., 1988). It has also been
shown in hepatoma cells that insulin can activate 
acetyl-CoA carboxylase by either inhibiting protein 
kinase activity or by stimulating the activation of 
protein phosphatases that control the
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phosphory 1 ation state of the enzyme (Witters ejt a 1 . ,
1988).
In mammary tissue, there is evidence that insulin 
action may be acting through an entirely different 
mechanism to that of phosphory1 ation of acetyl-CoA 
carboxylase, i.e. a dephosphorylation of acetyl-CoA 
carboxylase (Munday & Hardie, 1986a; Sommercorn et 
a 1. , 1987b). Refeeding for 2.5h reverses the
effects of 24h starvation and is accompanied by 
dephosphorylation (Munday & Hardie, 1986a). The 
effect of refeeding can be mimicked by the action of 
protein phosphatase 2A ijT. vitro, which would seem to 
indicate that insulin is probably responsible for 
the reversal of phosphorylation related to the 
inhibition of acetyl-CoA carboxylase (Munday & 
Hardie, 1986a). Dephosphory1ation and an increase 
in activity of acetyl-CoA carboxylase in liver in 
vivo has been demonstrated in rats subjected to 
hyperg1ycaemia; an increase in insulin accompanying 
the hyperg1ycaemia being responsible for the effects 
on acetyl-CoA carboxylase (Jamil & Madsen, 1987). 
From the foregoing it is evident that the way in 
which insulin modulates acetyl-CoA carboxylase 
activity is still unclear.
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1.3.2 Hormone-Sensitive Lipase
Hormone-sensitive lipase is the rate-1imiting step 
in the hydrolysis of triacy1g1ycero 1 s and catalyses 
the breakdown of stored triacy1g 1yceride first to 
DAG and then to monoacyl-g1yceride and free fatty 
acids. Lipolytic hormones, e.g. catecholamines, 
glucagon and ACTH, stimulate and insulin inhibits 
the activity of hormone-sensitive lipase (Belfrage 
et al ■ , 1980; Belfrage et_ a\_. , 1983a,b). 
Hormone-sensitive lipase activity is controlled by 
reversible phosphory1 ation/dephosphory1 ation 
(Steinberg & Huttunen, 1972; Steinberg e_t al_. , 1975; 
Steinberg, 1976; Severson, 1979). Phosphorylation 
by cyclic AMP-dependent protein kinase has been 
demonstrated in adipocytes (Belfrage et, a_l^. , 1977, 
1978), which closely parallels the activation of the 
enzyme (Fredrikson et. aj_* » 1981), the rate of 
phosphory1 ation being comparable with that found in 
intact cells (Belfrage e_t al_. , 1983a). 
Phosphorylation by cyclic AMP protein kinase occurs 
exclusively on a serine residue at one site of the 
two phosphorylation sites on the enzyme (Fredrikson 
et al . , 1981; Belfrage et_ a_l_. , 1983b; Stralfors &
Belfrage, 1983; Garton et al_. , 1988; Olsson & 
Belfrage, 1988). This site is termed the 
'regulatory' site as its phosphorylation mediates 
the change (inhibition) in activity. This 
'regulatory' site is phosphorylated in intact
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adipocytes in response to noradrenaline and other 
lipolytic hormones (Nilsson et a 1 . , 1980; Stralfors
& Belfrage, 1983; Stralfors ejt a_l_. , 1984) A second
basal' site appears to be insensitive to short-term 
modulation (Stralfors et. aj_. , 1984; Garton et. a 1 . ,
1988). Phosphorylation of the 'basal' site by 
either AMP-activated hormone or Ca2+- and 
calmodulin-dependent protein kinase has no direct 
effect on the activity of the enzyme, but it does 
greatly reduce the extent of phosphory1 ation and 
activation achieved subsequently by cyclic AMP- 
dependent protein kinase (Garton ejt aj_. , 1989).
This suggests that 'basal' site phosphorylation may 
have an anti 1 ipolytic role iji vivo and act as a 
feedback system (Hardie et_ al_. , 1989).
Dephosphory1 ation of hormone-induced phosphory1 ation 
can be brought about by incubation of adipocytes 
with insulin. It is accompanied by a decrease in 
hormone-sensitive lipase activity (Nilsson ejt a 1 . , 
1980; Nilsson, 1981). Insulin has no effect on 
basal hormone-sensitive lipase phosphatase activity, 
but incubation of adipocytes with insulin before 
exposure of cells to a lipolytic hormone prevents 
the increase in phosphory1 ation of hormone-sensitive 
lipase (Nilsson, 1981; Stralfors ej: ajL_. , 1984). It
is known that hormone-sensitive lipase in cyclic AMP 
treated cells is rapidly dephosphory1ated in 
parallel with the deactivation by a protein
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phosphatase from rat adipose tissue (Belfrage e_t 
a 1 . , 1983a,b; Olsson e_t aj^ . , 1984; Olsson &
Belfrage, 1987, 1988). Hence dephosphory1ation in
vivo could be a combination of inhibition of cyclic 
AMP-mediated phosphory1ation and the promotion of 
dephosphorylation by the activation of protein 
phosphatases (Nilsson e_t aj_. , 1980; Nilsson, 1981;
Stralfors et aj^ . , 1984). Recent work examining the
mode of insulin regulation of lipolysis in rat 
adipocytes, indicates that insulin affects the state 
of phosphory1ation of hormone-sensitive lipase via a 
cyclic AMP-dependent pathway, i.e. lowering the 
cyclic AMP concentration and through a cyclic AMP- 
independent pathway involving the activation of 
protein phosphatase activity, which together results 
in dephosphory1 ating both the regulatory and basal 
phosphorylation sites of hormone-sensitive lipase 
(Stralfors & Honnor, 1989).
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CHAPTER 2
MATERIALS AND METHODS
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2.1 RATS
Rats of the Albino Wistar strain, obtained from A 
Tuck & Son, Batt1ebridge, Essex, UK, were used for 
all experiments. The rats were fed ad^  1 i bi turn on 
Oxoid Breeding Diet (4 V. fat, 23*/. protein by energy)
(Oxoid Limited, Basingstoke, Hants, UK) and had 
access to water at all times. They were housed at a 
temperature of 20°C and on a 12 hour light:12 hour 
dark cycle, the light period beginning at 08:00 
hours.
For experiments described in Chapter 3 (Study of the 
regulation of mammary gland lipogenesis to insulin 
and glucagon during lactation), conditions were as 
foilows.
The rats were delivered to the animal house at 8 to 
9 weeks of age (body weight 180-200g) and were kept 
for at least 10-20 days before mating for use during 
lactation. At birth the litters were limited to 8 
pups. The dams weighed about 270g at 10-12 days 
lactation. Lactating rats used within 2 days 
post-partum are referred to as ear 1y-1actating rats 
and those used between 10 and 12 days post—partum as 
mid-1actating rats.
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For experiments described in Chapter 4 (Study of the 
regulation of adipose tissue lipolysis to glucagon 
during pregnancy and lactation), conditions were as 
fo1 lows.
The rats were bought in at 7 to B weeks of age (body 
weight 160-180g) and were kept for 2 days before 
mating for use during pregnancy and lactation, the 
time of mating being determined by the appearance of 
vaginal plugs. The pregnant and lactating rats were 
of approximately the same age (11-12 weeks) as the 
virgin rats in the same experiments. Virgin rats 
weighed 240-260g. Pregnancy lasted about 21 days, 
parturition occurring on day 22. Rats used on days 
19-20 of pregnancy are referred to as late pregnant 
rats and weighed 350-355g. At birth the litters 
were limited to 8 pups. Lactating rats that were 
used 1 day post-partum are referred to as 
ear 1y-1actating rats, (240-275g). Rats used between 
10 and 12 days post-partum are referred to as 
mid-1actating rats and weighed 270-320g.
All experiments were started between 09:00 hours and 
10:00 hours.
2.2 FEEDING
Starved rats were deprived of chow for the 24 hour 
period immediately preceding their experimental use.
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Animals referred to as starved-refed were starved 
for 24 hours, then refed chow for 2 hours before the 
experiment.
2.2.1 High-Energy Diets
Palatable high-energy diets have been used in 
previous studies to induce hyperphagia and obesity 
in rats (Sclafini & Springer, 1976; Agius et_ a 1 . , 
1980, 1981; Rolls e_t a_l_. , 1980). In this study, to
investigate the effects of alterations in energy 
intake on lactating rats, a high-energy 'cafeteria' 
diet was used. This consisted of cheese Cheddars 
and chocolate chip biscuits, and potato crisps.
These foods contain proportiona 1 1 y more fat (25-38’/. 
by energy) and less protein (5-11’/. by energy) (e.g. 
Rolls e_t al_. , 1980) than rat breeding diet chow.
The rats also had chow available ad libitum at all 
times. This diet was fed ad libitum to lactating 
rats for 7 days i.e. from day 3 to day 10 of 
1ac tation.
2.3 INSULIN DEFIENCY
Insulin deficiency was induced by injection of 
streptozotocin (Schein et aj_. , 1971). For long-term
insulin deficiency in lactating rats, a single 
intraperitonea1 injection of streptozotocin 
(50-100mg/kg body weight, delivered in 0.5ml of a
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0.01M citrate buffer, pH 4.5, (referred to later as 
50-100'/. strep tozotoc in doses)) was given three days 
after parturition and the animals were killed seven 
days later. A 5*/. glucose solution was substituted 
for water for the first 24 hours after the injection 
(Nosadini ejt aj_. , 1982).
2.3.1 Determination of Blood Glucose Concentration
This determination was made the day before the 
experiment. The rat was maintained under light 
halothane anaesthesia and a sample of blood was 
taken from the tail vein. An equal volume of 
perchloric acid (37. w/v) was added to a volume of 
blood, mixed and centrifuged at 1000 x g for 10 
minutes. The supernatant was removed and 
centrifuged again at 10,000 x g for 10 minutes in an 
Eppendorf 4312 centrifuge. The supernatant was 
diluted 100 fold and neutralised with 
triethanol amine hydroch1 oride/potassium hydroxide 
(0.5M/2M) to pH 7. The sample was centrifuged again 
at 10,000 x g for 10 minutes to remove precipitated 
potassium perchlorate. The sample was assayed for 
glucose by the method of Bergmeyer e_t a^. , (1974)
using a Gilford 250 spectrophotometer.
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2.4 MATERIALS
Fatty acid-poor albumin, adenosine, aprotinin, 
bacitracin, antipain, leupeptin, pepstatin, 
crystalline bovine insulin (24 U/mg), Ficoll 400, 
theophylline, pentobarbitone, adenosine 
trisphosphate (sodium salt), 
triethanol amine-hydrochloride,
tris(hydroxymethy1)-aminomethane, L-malic acid, 
NADP'*’, DNA (Calf Thymus, Type I), phospho (eno 1 ) 
pyruvate (trimonocyc1ohexy1 ammonium salt), Activated 
charcoal, Fraction V BSA, cyclic AMP (sodium salt), 
dithiothreitol, acetyl-CoA, mops
(4-morpholinepropanesu1 phonic acid), adenosine 
deaminase (EC 3.5.4.17), hexokinase (EC 2 . 7 . 1 . 1 ) ,. 
g1ucose-6-phosphate dehydrogenase (EC 1.1.1.49), 
pyruvate kinase (EC 2.7.1.40), L-lactate 
dehydrogenase (EC 1.1.1.27), g 1ycerokinase (EC 
2.7.1.30), protein kinase (3', 5'-cyclic AMP 
dependent) (EC 2.7.1.37) were obtained from Sigma 
Chemical Company Limited (Poole, Dorset, UK).
Streptozotocin was purchased from Upjohn Company 
(Ka1amazoo,M .I., USA).
Col 1agenase (EC 3.4.24.3) was type CLS III from 
Worthington (Lorne Diagnostics Ltd., Unit 11, 
Cratfield Road, Moreton Hall Industrial Estate, Bury
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St. Edmunds, Suffolk, IP32 7DF, UK) used for 
experiments in Chapter 3.
Collagenase (EC 3.4.24.3) from Clostridium 
histolyticum used for experiments in Chapters 3 and 
4 and NADH were from The Boehringer Corporation 
(London) Limited (Lewes, East Sussex, UK).
Crystalline pig glucagon was a gift from Lilley 
Research Laboratories (Indianapolis, IN, USA).
The tritiated water ( 3Ha0 ) (specific radioactivity 
5Ci/ml), cyclic (8-‘^H) AMP (specific radioactivity 
28Ci/mmol ) , and KHx<aC03 (specific radioactivity 
0.5Ci/mol) were from Amersham International pic 
(Aylesbury, Bucks, UK).
Compound Hoeschst H33258 (Bis-benzinoid) was 
purchased from Fluka A G (Buchs, Switzerland).
All other organic and inorganic chemicals were 
obtained from BDH Chemicals Limited (Poole, Dorset, 
UK) .
59
5 MEASUREMENT OF LIPOGENESIS IN MAMMARY ACINI AND
ADIP0CYTE5
5.1 Preparation of Rat Mammary Acini and Adipocytes 
(Chapter 3)
Rats were anaesthetised with pentobarbitone (60mg/kg 
body weight) at 09:30 hours; subsequent procedures 
up to the conclusion of the acini preparation were 
carried out in a warm room at 37°C. The 
inguina1/abdomina1 mammary glands were rapidly 
dissected and placed in oxygenated (02/C02,19 : 1 ) 
Krebs-Hense1eit (1932) bicarbonate buffered saline 
(120mM NaCl; 4.7mM KC1; 1.3mM CaC1 6FU0 ; 1 . 2mM 
KHJP0a; 1 . 2mM MgSO^. 7H.-0; 24mM NaHC03) containing 5mM 
glucose (referred to below as ’saline'). The tissue 
was minced with scissors and finely chopped with 
razor blades. The resulting minced tissue was 
rinsed twice in 5 volumes of 'saline' and 
resuspended in 30ml of 'saline' which contained 27. 
fatty acid —poor albumin, 57. dialysed Ficoll and 0.17. 
collagenase. The suspension was placed in a 250ml 
plastic conical flask, which was incubated with 
shaking (180 strokes/minute) for 60 minutes. The 
flask was gassed throughout with O^/CO^. The 
resulting digested tissue was strained through a 
nylon mesh (approximate1y 0.15mm mesh size) and the 
acini (not retained by the mesh) were washed 3 times 
and separated from adipocytes and ce11-fragments by
light centrifugation (400 x g, 15 seconds) from a 
medium containing 27. Ficoll in 'saline' . Finally 
the acini were resuspended in 6.5ml of 'saline' 
containing 2*/. Ficoll and 4*/. fatty acid-poor albumin.
Adipocytes from parametrial fat pad were prepared by 
a modification of the method of Rodbell (1964) using 
the same composition of the media as for acini 
except that Ficoll was omitted and 47. fatty acid- 
poor albumin was used in the digestion, washes and 
final suspension. The adipocytes were resuspended 
finally in 3.0ml of suspension medium.
2.5.2 Incubations of Acini and Adipocytes
Portions (1ml) of the final cell suspension of acini 
were dispersed into each of six 25ml plastic conical 
flasks, which contained 4ml of the same incubation 
medium, either without or with addition of hormones 
and/or effectors. The flasks were gassed with 
0S/C02 (19:1), stoppered and incubated, with shaking 
(180 strokes/minute) at 37°C for 15 minutes, after 
which time ImCi of 3H=0 (in IOOjjI) was added to each 
flask and incubations allowed to proceed for a 
further 45 minutes. Rates of incorporation into 
lipid by acini were determined to be linear over 
this time interval. At the end of the incubations 
the acini were separated by light centrifugation 
(400 x g, 15 seconds),, the supernatant was discarded
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and the acini were homogenised in 6ml
chloroform/methanol (2:l,v/v) with a Polytron tissue 
homogeniser (Kinematica, Basle, Switzer1 and) . 
Portions (1ml) of the final cell suspension of 
adipocytes were incubated as for mammary acini 
except that the incorporation of 3FUO was performed 
over 15 minutes after prior exposure to hormones for 
5 minutes. This was necessary to ensure linearity 
of 3H incorporation with time. At the end of the 
incubations the adipocytes were separated by light 
centrifugation (400 x g, 15 seconds).
2.5.3 Extraction of Acini and Quantification of Lipid 
Synthesis
Following the first extraction of acini with 
chloroform/methanol, after separation of acini and 
solvent by light centrifugation (400 x g, 15 
seconds) the solid matter was re-extracted with 
another 6ml of the same solvent mixture. To the 
combined extracts (12ml) were added 3ml of 0.88*/. KC1 
and 0.1ml of 6M HC1 The mixture was shaken and spun 
(400 x g, 5 minutes) to obtain two distinct phases. 
The upper phase was discarded and the lower phase 
was rinsed twice with 5ml of me t hano 1 /0.887.
KC1/chloroform (48:47:3 by volume). Finally the 
lower phase was filtered (Whatman No 1 filter paper) 
and evaporated to dryness in a rotary evaporator. 
When required a few drops of ethanol were added to
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ensure removal of traces of water. The dry residue 
was redissolved in 6ml of choroform/methano1 (9:1,
v/v), transferred to a scintillation vial and 
evaporated to dryness under a stream of nitrogen.
The residue was redissolved in 2ml of toluene. A 
portion of this toluene solution (0.95ml) was taken 
for measurement of radioactivity in the total 
lipid fraction. Another sample was taken for 
extraction of fatty acids as follows.
To 0.95ml of the toluene solution was added 2ml of 
methanol ic H3S04 (one volume of concentrated H^SO^. in 
100 volume of methanol). The mixture was heated at 
50°C overnight in a stoppered glass tube. It was 
subsequently cooled and extracted sequentially with 
4ml of n-heptane and 4ml of water. The upper phase 
was separated and retained. The lower phase was 
washed again with 4ml of n-heptane. The combined 
upper (organic) phases were washed with 3ml of water 
and the radioactivity remaining in the washed upper 
phase was measured to obtain a value for the 
incorporation of 3H into fatty acids. Radioactivity 
in a sample of the combined lower phase and washings 
was measured to obtain a value for the incorporation 
of 3H into acylglycerol glycerol. The scintillation 
cocktail that was used for radioactive counting in 
total lipid and fatty acid fractions was a toluene 
scintillator (supplied by Packard), whereas that 
used with other samples was an aqueous-compatible
formulation (Packard Scintillator 299). The 
specific radioactivity of 7H,0, in the acini- or 
adipocyte-free incubation medium (recovered from the 
centrifugation step by which the cells were isolated 
prior to lipid extraction), was determined by 
counting aliquots of this media. The radioactivity 
in the lipid extracts was expressed as umol 
3H20-equivalent5/minute/lOOmg defatted dry weight. 
Defatted dry weight was obtained from the remaining 
solid matter after extraction for lipid. This 
procedure was considerably more involved and lengthy 
than those used by other workers (see, e.g. Robinson 
& Williamson, 1977b). However, it was designed 
specifically for studying lipogenesis in mammary 
tissue, since it prevents the loss of short-chain 
fatty acids as their volatile methyl esters during 
subsequent extraction of the acini. Short- and 
medium-chain fatty acids form a substantial 
proportion of those synthesised by mammary tissue 
(Strong & Dils, 1972).
2.5.4 Quantification of Lipogenesis by Adipocytes
This was performed as described by Stansbie e_t a 1 . , 
(1976). After separation from their incubation 
medium by light cen tr i f uga tion, 3ml of 307. (w/v) KOH 
was added to the adipocytes and the mixture was 
heated on a hot block at 70°C for 30 minutes. 
Following saponification, the lipid was esterified
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by heating for a further two hours after adding 3m1 
of 957. (v/v) ethanol. After cooling, samples were 
acidified with 3ml 6M-H,-.S0A and the lipid was 
extracted with two 10ml volumes of petroleum ether 
(bp 40-60°C). The petroleum ether extracts of the 
saponified lipid were combined and washed three 
times with 10ml volumes of distilled water to remove 
contamination by 3H=:0 and other water-soluble 
tritiated substances, and they were evaporated to 
dryness. The dry residue was dissolved in 10ml of 
Scintillator 299 (Packard Instruments) and the 
radioactivity determined. The specific activity of 
^H^O in the incubation medium, obtained as an 
infranatant after centrifugal floatation of the 
adipocytes, was determined. The results were 
expressed as jumol H^.^ O incorporated into 
lipid/minute per rnLlnit of adipocyte NADP^-ma 1 a te 
dehydrogenase activity. This was assayed at S O ^  in 
the infranatant of a sample of adipocytes disrupted 
by vortex-mixing in a glass tube, using a coupled 
spectrophotometric assay as described previously 
(Zammit & Corstorphine, 1982b).
2.6 SPECIFIC BINDING QF x:ssI -LABELLED INSULIN AND 1=:gI- 
LABELLED GLUCAGON TO RAT MAMMARY ACINI
Acini were prepared as previously described in 
2.5.1. Specific binding and degradation of i2*l- 
labelled insulin (specific radioactivity 50-
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70jjCi/jug) were determined in the presence of 
bacitracin (600 Units/ml) as described by Flint 
(1982), except that the pH was 7.6 and the time of 
incubation was 24 hours. Identical protocols were 
followed to determine the binding and degradation of 
-1abe11ed glucagon (2.5ng/ml). Three 
labelled glucagon preparations, with .differing 
specific activities, were used as follows.
Experiment 1 
Experiment 2 
Experiment 3
Those used in experiments 1 and 2 were prepared from 
native glucagon by the ch1oroamine-T method, whereas 
that used in experiment 3 was a monoiodinated 
commercial product (NEN Chemicals, Dreiech,
Germany). Control experiments, used to correct for 
non-specific binding, were performed either by 
shortening the duration of the incubation (one hour, 
18°C) or by diminishing the extent of glucagon 
degradation (by using aprotinin, 2.5 Units/ml; 
pepstatin, 0.5mM; and antipain, 0.5mM, singly or in 
various combinations).
The measurements of insulin- and glucagon-binding in 
these experiments were performed by Dr. D.J. Flint.
52jjCi /jjg 
346^iCi /jjg 
295uCi /jjg
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2.7 DETERMINATION GF CYCLIC AMP LEVELS IN RAT MAMMARY
ACINI
2.7.1 Preparation and Incubation of Acini
Acini were prepared essentially as described before, 
except that the acini were finally resuspended in 
7.5ml of 'saline' containing 27. Ficoll and 47. fatty 
acid-poor albumin.
Portions (1ml) of the final suspension medium of 
acini were dispensed into each of five 25ml plastic 
conical flasks, which contained 6ml of the same 
incubation medium, either without or with addition 
of varying concentrations of theophylline. The 
flasks were gassed with O^/CO^, stoppered and 
incubated at 37<=>C with shaking (160 strokes/minute). 
For the zero time point, the cells were added to the 
incubation medium, mixed, and a 1ml sample was 
immediately removed for assay of cyclic AMP. For 
later time points, samples (1ml) were removed at 3, 
15, 30, 45 and 60 minutes. The incubations were 
stopped by adding the sample to ice-cold perchloric 
acid (final concentration 57.). They were then mixed 
and rapidly frozen in liquid nitrogen. Such samples 
could then be stored for up to four weeks without 
any decrease in cyclic AMP levels.
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2.7.2 Determination of Cyclic AMP Concentration
The cyclic AMP assay is based on the competition 
between unlabelled cyclic AMP and a fixed amount of 
the tritium labelled compound for binding to a sub- 
stoichiometric quantity of a protein which has a 
high affinity and specificity for cyclic AMP (Method 
of Gilman, 1970 as modified by Tovey e_t aj^ . , 1974).
When equilibrium has been reached between cyclic AMP 
binding protein and the cyclic AMP present, 
measurement of the protein-bound radioactivity 
enables the amount of the unlabelled cyclic AMP in a 
sample to be calculated.
A standard curve relating known concentrations of 
cyclic AMP based on the above principle was 
prepared. The cyclic AMP concentration of unknowns 
could be determined with reference to the 
calibration curve. The standards were prepared by 
diluting a stock cyclic AMP solution with assay 
buffer (50mM-Tris-HCL, 4mM-EDTA, pH 7.0) to the 
appropriate final concentrations (0-160 pmol/ml) on 
the day of the assay. The standards were treated 
with perchloric acid in the same way as were the 
unknown samples and also subsequently treated in 
exactly the same way as unknown samples.
All assay procedures were carried out in duplicate 
at 0'=C. To aliquots (50jul) of unknown sample or
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standard cyclic AMP solutions were added 50|_il 
(0.025j_iCi; 0.89pmol) of [sH]-cyc 1 ic AMP in assay 
buffer, 80jj1 of assay buffer and 20jjl of binding 
protein solution (0.4mg cyclic AMP dependent-protein 
kinase/ml assay buffer containing 5mg/ml BSA). 
Control or 'charcoal blank' tubes contained 20jul of 
assay buffer instead of binding protein solution. 
Each tube was mixed for five seconds and left to 
stand on ice for at least two hours in order to 
allow equilibrium binding of cyclic AMP in samples 
containing up to 8pmol of cyclic nucleotide. Then 
to each tube was added lOOjjl charcoal suspension 
(2.6mg activated charcoal/ml assay buffer containing 
2mg/ml BSA). This was mixed and left on ice for 1.5 
minutes, then spun at 10,000 x g for two minutes in 
an Eppendorf centrifuge. Unbound cyclic AMP was 
adsorbed onto the charcoal at this step. The 
fraction of [3H]-cyclic AMP that was bound to the 
binding protein remained non-sedimentable and was 
quantified by withdrawing a 200jj 1 sample of the 
supernatant and adding it to 10ml of Scintillator 
299, prior to the determination of radioactivity in 
a scinti11 ation counter. Results were expressed as 
pmol cyclic AMP/g wet weight of acini.
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2.8 MEASUREMENT OF ACETYL-COA CARBOXYLASE ACTIVITY IN
MAMMARY ACINI
The preparation and incubation of mammary acini was 
as described in section 2.5.1 with the exception 
that an aliquot (lOOjul) of non-radioac ti ve water was 
used. At the end of the incubations, the acini were 
separated by light centrifugation (400 x g, 15 
seconds) and frozen in liquid nitrogen. They were 
subsequently stored frozen at -30°C.
2.8.1 Preparation of Homoqenates
The frozen acinar pellets were weighed, powdered 
with a spatula cooled in liquid nitrogen and 
homogenised (two periods of 10 seconds) with a 
polytron tissue homogeniser in 1.5ml of ice-cold 
extraction medium containing 0.25M-sucrose, 20mM- 
Tris, 20mM-Mops, ImM-dithiothreitol, 2mM-EDTA and 
2mM-EGTA, pH 7.4 at 4C>C. Fatty acid-poor albumin 
(lOmg/ml) was added to the homogenate, which was 
immediately centrifuged at 10,000 x g for 60 seconds 
in an Eppendorf 5412 centrifuge.
2.8.2 Assay of Acetvl-CoA Carboxylase Activity
Acetyl-CoA carboxylase activity was assayed at Z0°C 
as described by Brownsey et a 1. , (1979) . The assay
medium contained lOOmM-Tris/acetate, 0.5mM-EDTA,
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lOmM-magnes ium acetate, ImM-d i thiothrei to 1 , 150jjM-
acetyl-CoA, 5mM-ATP, 20mM-magnesium citrate, 15mM 
KH^CO-j. and lOmg of fatty acid-poor albumin/ml in a 
total volume of 0.45ml contained in stoppered 
plastic tubes. The final pH was 7.4. The sample 
was incubated at for one minute before assaying
in order to heat the sample to the same temperature 
as that of the assay mix. The reaction was 
initiated by addition of 20|_il of sample either (i) 
immediately or (ii) after pre-incubation for 15 
minutes in the presence of 20mM-potassium citrate. 
They were terminated at either (a) 60 seconds and 
120 seconds for condition (i) or (b) 30 seconds and 
60 seconds for condition (ii) by addition of 0.1ml 
of 6M-HC1. Results determined in (i) represent the 
Initial activity (I) of acetyl-CoA carboxylase. 
Results determined in (ii) represent the citrate 
activity (C) of acetyl-CoA carboxylase. For 
controls, conditions were as for (i) and (ii), 
except that acid was added before the addition of 
the sample.
9 MEASUREMENT OF GLYCEROL RELEASE BY ADIPOCVTES
9.1 Preparation of Adipocytes from Parametrial Fat
Rats were anaesthetized with pentobarbitone (60mg/Kg 
body weight) at 09:30 hours, all subsequent 
procedures were carried out in a warm room at 37°C.
The parametrial fat pads from one rat were rapidly 
dissected from the urinogenital tract, then rinsed 
in oxygenated (O^/CO-,, 19:1) Krebs-Hense 1 ei t (1932)
bicarbonate-buffered saline (120mM NaCl; 4.7mM KC1; 
1. 3mM CaCls.6Ha0; 1 . 2mM KH^PO^; 1 . 2mM MgS0*.7H=0; 
24mM NaHC03) containing 5mM—g 1ucose (referred to 
below as 'saline') and finely minced. Adipocytes 
were prepared using the technique of Rodbell (1964) 
as follows. The minced adipose tissue was divided 
between three flasks; each flask contained 5ml of 
'saline' which contained 4*/. fatty acid-poor albumin 
and 37. col lagenase. The suspensions were incubated 
with shaking (160 strokes/minute) for 60 minutes. 
The resulting digested tissue was strained and the 
adipocytes were washed twice by centrifugal 
floatation from the same basal medium (without 
collagenase) and finally resuspended in a total of 
16ml .
2.9.2 Incubations of Adipocytes
Portions (1ml, containing approximately 10* cells) 
of the cell suspension were dispensed into each of 
fourteen 25ml plastic conical flasks, which 
contained 4ml of the same basal medium, either 
without or with addition of hormones and/or 
effectors. The flasks were gassed with O^/CO-. 
(19:1), stoppered and incubated at 37°C in a shaking 
water bath (160 strokes / minute) for 50 minutes.
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Rates of glycerol release by adipocytes were 
determined to be linear over this time interval. At 
the end of the incubations the adipocytes were 
separated from the medium by light centrifugation.
To 4.5ml of the medium was added 0.45ml 45*/. (w/v) 
ice-cold perchloric acid. The acidified sample was 
spun at 1000 x g for 10 minutes. The supernatant 
was removed and to it was added 0.25ml 
triethanolamine-HC1 (1M), followed by a saturated
solution of KaC03 until neutrality was achieved 
(using universal indicator). The resulting extract 
was centrifuged again at 1000 x g for 10 minutes.
The supernatant was retained and kept on ice for the 
assay of glycerol.
2.9.3 Glycerol Assay
Glycerol was assayed spectrophotometrica11y at 340nm 
using a Gilford 250 spectrophotometer by the method 
of Garland & Randle (1962). The assay medium in 
2.0ml contained 0 . ImM-tr iethanol amine-HC 1 /6mM- 
magnesium sulphate/2mM-potassium hydroxide, pH 7.6, 
3mM-NADH, 75mM-ATP, pH 7.0, 35mM-PEP, 20mU-pyruvate 
kinase, 200mU-L-1actic dehydrogenase and sample from 
which a base line was obtained. The reaction was 
started with the addition of g1ycerokinase (2mU) and 
allowed to go to completion. The difference between 
the two steady states gave a measure of the amount 
of glycerol in the sample. Glycerol release from
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adipocytes was expressed as ^jmol/hour/109 cells or 
Limol/hour / 10 mg DNA .
2.10 MISCELLANEOUS PROCEDURES
2.10.1 Cell Number Determinations
Adipocyte size was determined as described by Vernon 
(1977). A sample of the cell suspension was placed 
in a haemocytometer which was mounted on the stage 
of a projecting microscope. The diameter of 100 
cells was measured and from this the adipocyte 
volumes and mean volume were calculated. A dry 
weight determination was made on a 200^1 sample of 
the final suspension of cells by drying to constant 
weight in an oven at 60°C. From these 
determinations it was possible to calculate the 
number of cells per 1ml of cell suspension by making 
the assumption that 1ml adipocyte volume accounted 
for a weight of 0.91g.
2.10.2 DNA Determination
An aliquot (1ml) of adipocyte suspension was 
disrupted by vortex-mixing in a glass tube. The 
suspension was left to stand at room temperature for 
five minutes, then at 4°C for 15 minutes. The 
infranatant was removed and an equal volume of ice- 
cold ether was added. The tubes were mixed
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thoroughly and left to stand for five minutes. This 
was followed by slow centrifugation. The ether 
layer was removed as completely as possible, and any 
remaining ether was evaporated using a stream of 
air. The samples were then diluted 20-fold with a 
medium (A) containing 0.OlmM-NaPO^ and 2.0M-NaCl; pH
7.4.
The DNA content of the samples was measured by 
monitoring enhancement of fluorescence that occurred 
on addition of bisbenzimidazole (Hoechst 33258) to 
the DNA-containing sample (Labarca & Paigen, 1980). 
Stock solutions of DNA (200|jg/ml) were prepared in 
2mM EDTA and stored at -80°C. DNA standards were 
prepared by diluting stock DNA solution with 
phosphate-sa1ine buffer to the appropriate final 
concentration (0-20jjg/ml) on the day of the assay.
A stock solution of fluor (H33258) (200^ig/ml) was
prepared and stored at 4CSC. On the day of the 
assay, this stock solution was diluted with medium A 
to a final concentration of 2jjg/ml.
To duplicate aliquots (500j_il) of unknown sample or 
standard DNA solutions were added 500j_il fluor. For 
'unknown sample blanks' 500pl of medium A was added 
instead of fluor to aliquots of unknown samples.
Each tube was mixed and left to stand at room 
temperature for at least one hour, before reading 
fluorescence at an excitation wavelength 355nm and
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an emission wavelength 445nm using a Baird Atomic 
F 1uorimeter.
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CHAPTER 3
STUDY OF THE REGULATION OF MAMMARY GLAND LIPOGENESIS 
BY INSULIN AND GLUCAGON DURING LACTATION
77
The aims of this study were two fold
(a) To determine the way in which mammary gland 
lipogenesis is regulated; the effects of glucagon 
and other agents (which are known to affect lipid 
metabolism in adipose tissue) on the rates of 
lipogenesis and the activity of acetyl-CoA 
carboxylase in acini isolated from the mammary gland 
of fed mid-1actating rats were studied.
(b) To determine the effect of insulin on the rates of 
lipogenesis in acini isolated from the mammary 
glands of rats at different stages of lactation, and 
in acini isolated from mid-1actating rats that were 
subjected to various physiological (and
pathologica1 ) conditions. Starvation, diabetes and 
cafeteria-feeding were studied. From these data of 
the dose-response characteristics of different acini 
with respect to insulin, the sensitivity to insulin 
of mammary lipogenesis under different conditions 
could be determined.
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3.1 STUDY OF THE RATES OF LIPOGENESIS AND THE ACTIVITY
OF ACETYL-COA CARBOXYLASE IN ACINI ISOLATED FROM THE 
MAMMARY GLANDS QF FED MID-LACTAT ING RATS
3.1.1 Lipogenesis
The absolute rates of 7H incorporation into fatty 
acids by acini in the absence of any additions were 
similar to the rates of fatty acid synthesis 
reported previously by other workers (Robinson & 
Williamson, 1977c; Munday & Williamson, 1981).
Ex per i men ts in which the incorporation of into
lipid was measured as a function of time 
demonstrated that rates of lipogenesis were linear 
between 5 and 60 minutes. Subsequently rates were 
measured routinely between 15 and 60 minutes, the 
initial 15 minute period being used to ensure the 
attainment of the full response to the effectors 
added. The incorporation of label into acylglycerol 
glycerol is about 207. of that into fatty acids under 
all conditions studied.
3.1 .1 . 1 Effects of Glucagon
Incubation of acini with glucagon had no effect on 
the rates of synthesis of total lipid or fatty acids 
(Table 3.1). The concentration of glucagon used in 
the present study was about 100—fold higher than 
those found to give a maximal inhibitory response on
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acetyl-CoA carboxylase activity in adipocytes 
(Zammit & Corstorphine, 1982b). This high
concentration was used to ensure that degradation of 
the hormone by the acini did not significantly 
deplete the incubations of glucagon. The complete 
lack of effect of glucagon on the rate of 
lipogenesis in mammary acini was in contrast with 
the inhibition of lipogenesis observed in adipocytes 
(Table 3.2) and in agreement with results of two 
determinations reported by Williamson ejt a_l_. , (1983)
since these experiments were performed. More recent 
work involving the infusion of glucagon into fed 
lactating rats, at a rate sufficient to cause a 5-6 
fold increase in the plasma concentration of the 
hormone (Soman & Felig, 1978), indicated that no 
change in the rates of lipogenesis in the liver, 
mammary gland or adipose tissue could be elicited 
(Jones et a_l_. , 1984a), although adipose tissue rates
tended to be lower.
To further investigate these results, the specific 
binding of -1abel1ed insulin and 1=,I-1abe11ed
glucagon to rat mammary acini were studied. These 
results (Table 3.3) showed that the specific binding 
and degradation of 1=:®i-1abe11ed insulin were similar 
to those reported by Flint (1982) for mammary acini 
of 10 day lactating rats. However, significant 
specific binding of 1=*i-glucagon to preparations of 
acini could not be detected, suggesting that, unlike
80
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that in adipose tissue, mammary tissue lipogenesis 
is not likely to be sensitive to circulatory 
glucagon in_ vi vo .
3.1.1.2 Effects of Insulin
Inclusion of insulin in the incubation medium 
resulted in a marked stimulation (50-607.) of 
lipogenesis in mammary acini (Table 3.1). This 
stimulation was much larger than that observed 
previously (Robinson & Williamson, 1977a; Agius & 
Williamson, 1980; Williamson e_t a_l_- * 1983) for acini
prepared from lactating rats fed on a comparable 
diet, although a similar degree of stimulation by 
insulin was reported by the same workers when they 
used acini isolated from rats fed on a high-energy 
diet (Agius & Williamson, 1980). The reason(s) for 
these differences are unclear, though Williamson ejt 
al_. , (1983) have proposed that the low percentage
stimulation by insulin obtained by them may be due 
to lack of another effector(s) such as the 
gastrointestinal peptide, that acts synergistical1y 
with insulin in_ vivo (Page, 1989). Rates of 
lipogenesis in_ vivo (Robinson ejt al_. , 1978; Agius & 
Williamson, 1980) are much higher compared to those 
reported in v i tro (Robinson & Williamson, 1977a; 
this thesis), but there is a parallelism between in 
vivo and in. v i t ro. Incubation of acini with both 
insulin and glucagon in the incubation medium did
8 1
not have any significant effect on the rate of 
lipogenesis in acini, compared with the rates 
obtained when insulin alone was added, contrary to
the antagonistic effects of the two hormones in
adipocytes (Zammit & Corstorphine, 1982b; Green, 
1983). Moreover, glucagon did not affect the 
sensitivity to insulin of lipogenesis by acini, as 
judged by its 1ack of effect on the dose-response 
curve for insulin (Fig. 3.1).
3.1.1.3 Effects of Fhosphodiesterase Inhibitor
Theophylline is known to augment an increase in the 
concentration of cyclic AMP by inhibiting cyclic AMP
phosphodiesterase and/or as antagonist of the
adenosine A^-site in tissues in which the inhibitory 
A^-site predominates. In experiments with
adipocytes, incubation with theophylline results in 
inhibition of lipogenesis (Trost & Stock, 1979). 
Therefore, in order to test whether glucagon might 
have an inhibitory effect on lipogenesis in mammary 
acini by augmenting -the potential effects of 
theophylline, experiments were performed in which 
either glucagon or insulin was added to the 
incubation medium simultaneously with theophylline 
(5mM). Theophylline at this concentration inhibited 
the rate of lipogenesis by about 15*/. (Table 3.4, 
experimental series I). Glucagon did not augment 
this effect. However, insulin still had a
82
Fig3.1 Dose—response curve for the effect of insulin on the rate 
of lipogenesis by mammary—gland acini in the absence 
or presence of glucagon.
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Acini were incubated as described in Materials and 
Methods chapter for 15min. in the presence of either 
glucagon (2jjg/ml) or insulin (ljjg/ml). After 15 
min. , rH s0 (IOOjjI, containing imCi ) was added and 
the incubations were allowed to proceed for a 
further 45 min.. The acini were separated from the 
medium by centrifugation and extracted as described 
in the Materials and Methods chapter. Values are 
means ± S.E.M. for three separate determinations.
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stimulatory effect on lipogenic rates in the 
presence of theophylline (Table 3.4).
3.1.1.4 Effects of Adenosine
A similar series of experiments was performed with 
adenosine and adenosine deaminase, which, in adipose 
tissue, induce lipogenic and anti1ipogenic effects 
respectively (Trost & Stock, 1979; Honnor & 
Saggerson, 1980; Vernon ejt aX- , 1983, 1987; Zammit, 
1988). Neither adenosine nor adenosine deaminase 
affected the lipogenic rates of mammary acini (Table
3.4, series II). Glucagon added in combination with 
adenosine deaminase also did not result in any 
inhibition of the rate of lipogenesis (Table 3.4). 
Both adenosine and adenosine deaminase were added to 
acini at concentrations in excess of those required 
to elicit their respective responses in adipose 
tissue. However, the apparent unresponsiveness of 
acini to these agents has to be interpreted with 
caution, since the amounts of cell protein in these 
incubations were much' higher than those involved in 
adipocyte incubations (e.g. Zammit & Corstorphine, 
1982b). Therefore rates of production and/or 
destruction of adenosine in incubations of acini 
could be much higher, thus tending to mask the 
effects of exogenously added adenosine or adenosine 
deaminase.
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3.1.1.5 Effects of Cyclic AMP
The observation that theophylline, when added to the 
incubation medium at a concentration of 5mM, gave a 
modest but significant inhibition of lipogenesis in 
acini prompted us to study the dependence of the 
extent of inhibition on increasing theophylline 
concentrations (Fig. 3.2). The results suggest that 
theophylline, in the concentration range normally 
used in studies on isolated adipocytes to increase 
intrace11u 1ar concentrations of cyclic AMP and 
stimulate lipolysis (Mosinger & Vaughan, 1967; 
Steinfelder & Joost, 1982), is a potent inhibitor of 
lipogenesis in mammary acini. Direct measurements 
of cyclic AMP concentration in mammary acini showed 
that the inhibitory effects observed with 
theophylline on lipogenic rates were accompanied by 
a rise in the concentration of the cyclic nucleotide 
(Fig. 3.3). The concentration of cyclic AMP in 
mammary acini from fed rats was increased 2-3 fold 
over controls in the presence of 20mM theophylline. 
However, at the lowest concentration tested (5mM), 
theophylline was without statistically significant 
effect on cyclic AMP content of acini (Fig. 3.3).
The concentration of cyclic AMP in freshly prepared 
acini diluted into incubation medium in the absence 
of theophylline was similar to that reported 
previously for milk-free rat mammary tissue (Sapag- 
Hagar & Greenbaum, 1974).
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Fig3.2 Effects of theophylline on the rate of incorporation 
of from 3 ^ 0  into total lipid and fatty acids by rat 
m am m ary gland acini.
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Acini were incubated with the appropriate 
concentration of theophylline for 15 min., and the 
rate of incorporation of 3H was measured over the 
following 15 min. after addition of lmCi of Hxo,
Fig3.3 Theophylline—induced increase in intracellular 
cyclic AMP content of mammary acini: effect of 
duration of incubation.
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a ------ a  10mM Theophylline
a ----- ▲ 15mM Theophylline
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Time of incubation (min)
Acini from fed lactating rats were incubated at 
37°C for the times indicated, in the absence of 
theophylline (0) or in the presence of theophyllin 
at a concentration of 5mM (0), lOmM ( a ) , 15mM ( A )  
or 20mM (□), before samples were rapidly quenched 
in HC104 and their content of cyclic AMP was 
measured. Bars indicate S.E.M. values around the 
means plotted, which are from five separate 
preparations incubated at each theophylline 
concenatration.
The sensitivity of the response of intrace 1 1u 1ar 
cyclic AMP to theophylline was increased in mammary 
acini isolated from lactating rats that had been 
starved for 24h (Fig. 3.4). Comparison of values 
measured in the presence of theophylline to those 
measured for the corresponding group in the absence 
of theophylline (tested by Student's t test for 
paired samples) indicated that for fed rats, 10mM-, 
15mM- and 20mM-theophy11ine values, and for starved 
rats, 5mM-, 10mM-, 15mM- and 20mM-theophy11ine
values, were significantly different (Fig. 3.4). 
Group mean values were significantly different 
(Student's t test, P<0.05) between acini from fed 
and starved rats at 5mM~, lOmM- and 15mM- 
theophy11ine.
There was a positive correlation (coefficient
0.9705) between the percentage inhibition of 
lipogenesis and the concentration of cyclic AMP in 
mammary acini measured at the end of the incubation,
1.e. after 60 minutes (Fig. 3.5). This observation 
suggested that the inhibition of lipogenesis by 
theophylline was related to a rise of the cyclic AMP 
concentration, but does not necessarily indicate a 
causal relationship between the two parameters.
The cyclic AMP concentrations in acini discussed 
above were those measured after 60 minutes of 
incubation at 37C5C. Measurements were also made at
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Fig3.4 D o se -d ep en d en t increase in intracellular cyclic AMP 
content of m a m m a ry  acini treated with theophylline.
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Acini prepared from either fed (0 ) or 24h-starved 
lactating rats ( a )  , were incubated at the indicated 
concentrations of theophylline and sampled as in 
Fig. 3.3. The mean cyclic AMF concentrations after 
incubation of acini (five separate preparations 
from rats in each state) for 15 min. are plotted; 
bars indicate S.E.M. Values significantly 
different from those measured for the 
corresponding group in the absence of theophylline 
(tested by Student's t test for paired samples) are 
indicated as follows : + , *, P<0.05; -j-f, **,
P < 0 .0 1 ;  +t+» ***, P<0.001. Group mean values were 
significantly different (Student's t test, P<0.05) 
between acini from fed and starved rats at 5mM-, 
lOmM- and 15mM-theophylline.
Fig3.5 Correlation between intracellular cyclic AMP content and 
inhibition of lipogenesis provoked by treatm ent of 
mammary acini with theophylline.
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Values for inhibition of lipogenesis are calculated 
from Fig. 3.S on the effect of theophylline on the 
rate of lipogenesis in rat mammary acini; in that 
work, lipogenesis was measured as an average rate 
between 15 and 60 min. of incubation. Linear- 
regression analysis by the least squares method 
gave the line shown, with a correlation coefficient 
of 0.9705.
other time-points during incubations of acini with 
or without theophylline. Cyclic AMP concentrations 
were not constant during 60 minutes of incubation 
but decreased. The rate of this decrease was rapid 
during the initial phase of the incubation (0-5 
minutes) except at the highest concentration of 
theophylline tested (20mM), and then much slower 
between 15 and 60 minutes (Fig. 3.3). At all 
concentrations of theophylline tested and also in 
its absence, the cyclic AMP content was 
significantly lower at 60 minutes than at time zero. 
However, using Student's t-test for paired samples, 
it was ascertained that there was a significant 
decrease in cyclic AMP between 15 minutes and 60 
minutes of incubation in the presence of 5mM 
(p<0.05) and 20mM (p<0.01) theophylline, but not in 
its absence.
These values, at any given concentration of 
theophylline, could justifiably be pooled all 
together at times between 15 and 60 minutes for the 
plot of theophylline concentration and percentage 
inhibition of lipogenesis, since lipogenesis was 
measured by incubation throughout the same
interval. Qualitatively, similar results were 
obtained to those given in Figs. 3.4.and 3.5 
respectively. In the case of the latter plot, the 
correlation coefficient actually increased slightly
8 6
to 0.9747 when the data were handled in this way 
(Fig. 3.6).
The reasons for the observed biphasic pattern of 
decline in cyclic AMP concentration are not clear.
It is possible that the initially high levels of 
cyclic AMP in freshly prepared acini bring about an 
activation of phosphodiesterase (as found in liver 
cells treated so as to increase intracellular cyclic 
AMP (Houslay et a_l_. , 1983a)), this giving a rapid
breakdown of the cyclic nucleotide over the first 15 
minutes which slows down as the cyclic AMP 
concentration reaches a new near-steady state.
Since theophylline (a methy 1xan thine) is an 
inhibitor of phosphodiesterase (as well as an 
antagonist of the adenosine A± site) theophylline 
(20mM) would therefore be expected to attenuate the 
decrease in cyclic AMP observed in its absence as 
seen in Fig. 3.3. If the effects of theophylline on 
acinar lipogenesis are mediated through this effect, 
the persistence of the lipogenic effect of insulin 
(Table 3.4) under these conditions would be 
compatible with the known ability of insulin to 
reverse modest increases in intrace 11u 1ar 
concentrations of cyclic AMP in isolated adipocytes 
(Manganiello e_t al_. , 1971) and hepatocytes (Pilkis
et a 1. , 1975). However no comparable effect was
found to accompany insulin treatment of mammary 
acini in the presence of a isobutyl methyl xanthine,
Fig3.6. Correlation between intracellular cyclic AMP content 
and inhibition of lipogenesis provoked by treatment 
of mammary acini with theophylline.
_c
*
10 12 14 
10 ^ x cyclic AMP content 
(p m o l/g  wet wt. of acini)
Values for inhibition of lipogenesis are calculated 
from Fig. 3,3 on the effect of theophylline on the 
rate of lipogenesis in rat mammary acini; in that 
work, lipogenesis was measured as an average rate 
between 15 and 60 min. of incubation. Cyclic AMP 
content at corresponding theophylline 
concentrations (0, 5, 10, 15 and 20mM) are 
therefore averages of values recorded from five 
separate preparations from fed lactating rats at 
15, 30, 45 and 60 min. of incubation. Linear- 
regression analysis by the least squares method 
gave the line shown, with a correlation coefficient 
of 0.9747.
isoprenaline (Clegg & Mullaney, 1985). This and 
other results suggest that the rate of lipogenesis 
and the cyclic AMP content in mammary acini can vary 
independently of one another. Indeed, there are 
reports of antagonism by insulin of the effects of 
adrenaline which is not accompanied by any change 
in cyclic AMP concentration (e.g. in muscle) 
(Walkenbach et_ a_l_* ? 1980). In addition, the
necessity for insulin-mediated depression of cyclic 
AMP concentration in the mechanism of insulin action 
has been disputed (Gabbay & Lardy, 1984, 1986). 
However there is evidence that insulin can reverse 
cyclic AMP accumulation in adipocytes up to a 
certain percentage stimulation of lipolysis, whereas 
at greater levels of stimulation another mechanism 
of antagonism occurs (as yet unidentified) (Beebe et 
al . , 1985; Honnor et al_- » 1985; Londos et_ al . «
1985).
3.1.2 Acetvl-CoA Carboxylase
3.1.2.1 Effects of Insulin
Insulin had no effect on acetyl-CoA carboxylase 
activity in mammary acini (Table 3.5), unlike the 
effect of insulin stimulation of lipogenesis in 
acini (Table 3.1). These results are contradictory 
to the many reports of insulin activation of acetyl- 
CoA carboxylase in many tissues, including the
8 8
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mammary gland i£^  v i t ro and in_ vivo (Halestrap & 
Denton, 1973, 1974; McCormack & Denton, 1977;
Witters et a 1 . , 1979; Monday & Williamson, 1982;
Buechler et_ a_l_* i 1984; Clegg & Calvert, 1988). The 
lack of effect of insulin on acetyl-CoA carboxylase 
observed above could be accounted for by the 
possibility that the enzyme in isolated acini may 
already be in a fully dephosphory1 ated state, at 
least with respect to the 'insulin site(s)'. An 
alternative hypothesis is that the effect of insulin 
on lipogenesis in mammary acini may not be the 
result of action on acetyl-CoA carboxylase.
3.1.2.2 Effects of Theophylline
Acini were exposed to 20mM theophylline for 60 
minutes, and acetyl-CoA carboxylase activity was 
measured. No effect of theophylline was observed 
(Table 3.5) compared to the 607. decrease observed 
for lipogenesis (Fig. 3.2). As suggested previously 
for insulin, the effect of theophylline on 
lipogenesis may not be mediated through acetyl-CoA 
carboxylase, despite the observation that 
theophylline does increase the cyclic AMP 
concentration in mammary acini. Although this could 
be expected to trigger the mammary gland protein 
kinase thought to have properties very similar to 
AMP-activated protein kinase found in hepatocytes 
and adipocytes (Carling & Hardie, 1986; Carling e_t
89
a 1. , 1987; Sim & Hardie, 1988). It is, however,
possible to envisage circumstances under which this 
alone would not lead to an increase in the steady- 
state phosphorylation of acetyl-CoA carboxylase.
The possibility exists that this protein kinase may 
be inactive in mammary acinar preparations.
Data presented in Table 3.6 are part of a 
preliminary investigation into the activity of 
acetyl-CoA carboxylase in mammary acini. Due to the 
nature of the results, no further work was done in 
this area, and hence as they stand they should be 
taken as indicative of the possible lack of effect 
of adenosine and adenosine deaminase on acetyl-CoA 
carboxylase, which supports earlier findings using 
these effectors on lipogenesis in acini (Table 3.4).
3.1.2.3 Effects of Glucagon
Glucagon had no effect on the activity of acetyl-CoA 
carboxylase in acini (Table 3.6) which supports 
findings presented earlier (Table 3.1) on the lack 
of effect of glucagon on lipogenesis in acini. By 
analogy with the accepted mode of action of 
glucagon, if the hormone were to exert an effect on 
acetyl-CoA carboxylase, it might be through the 
mammary gland protein kinase. This is through the 
same mechanism described for theophylline and 
therefore it is possible to envisage similar
90
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conditions occurring for glucagon as discussed for 
theophy11ine.
At low concentrations (5mM), theophylline did not 
appear to have an effect on the activity of acetyl- 
CoA carboxylase (Table 3.6). Addition of insulin at 
the same time as 20mM theophylline had no 
significant effect either. This result was perhaps 
surprising in view of earlier reports (Table 3.4) of 
the ability of insulin to reverse the effect of 
theophylline on lipogenesis.
Overall, acetyl-CoA carboxylase activity did not 
respond under any conditions, and only the effects 
of glucagon and adenosine correlated with results 
obtained with lipogenesis (section 3.1.1).
3.2 STUDY OF THE RATES OF LIPOGENESIS IN ACINI ISOLATED 
FROM THE MAMMARY GLANDS OF RATS AT DIFFERENT STAGES 
OF LACTATION AND IN ACINI ISOLATED FROM MID- 
LACTATING RATS THAT WERE SUBJECTED TO VARIOUS 
PHYSIOLOGICAL (AND PATHOLOGICAL) CONDITIONS
A variety of physiological and pathological 
conditions were studied in the lactating rat. A 
summary of the main observations to arise from the 
insulin dose-response experiments follows, with the 
results being expressed relative to those for the 
fed mid-1actating rat mammary acini.
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(i) 24h starvation and long-term diabetes both
resulted in a large decrease in lipogenesis, but 
long-term diabetes resulted in an increase in 
sensitivity to insulin, whereas 24h starvation 
had no effect on the sensitivity to insulin.
(ii) Acini from early lactating rats had a low rate 
of lipogenesis and decreased sensitivity to 
insu1 in.
(iii) 2h refeeding of 24h starved rats resulted in a 
partial reversal of the rate of lipogenesis
(iv) Acini from Cafeteria-fed mid-1actating rats 
showed no significant change in the rates of 
lipogenesis, though the sensitivity was 
dec reased.
3.2.1 Effects of Different Stages of Lactation
Incubation of acini, from fed mid-1actating rats, 
with insulin resulted in the stimulation of 
lipogenesis (Figs. 3.7 & 3.8). The maximal 
stimulation observed (about 50 — 60*/.) was obtained at
from the starved value to the fed value, and
was accompanied by a decreased sensitivity to
insulin relative to acini from the 24h starved
and fed mid-1actating rats.
of insulin above 168uU/ml (Figs. 3.7
92
F ig 3 .7 . D o s e —re s p o n s e  c u rv e s  fo r  th e  ra te  of in c o rp o ra tio n  
H fro m  ^ H o O  in to  th e  to ta l lip id by ac in i fro m  m a m m a ry  g la n d s  
la c ta tin g  ra ts  u n d e r d if fe re n t  p h ys io lo g ica l s ta te s .
1.0 x
0.8 --
2 3
log [insulin] (jiU /m l)
Acini were prepared from mammary glands of normal, 
fed early,-lactating rats (□) or from mid-lactating 
rats that were fed a normal (■) or cafeteria 
diet (▲) or that were made diabetic (a ), or starved 
for 24h (#) or starved and refed (2h) (0). See 
Materials and Methods chapter for experimental 
treatments. The values shown are means (±S.E.M.) 
for the number of determinations given for the 
corresponding data in Table 3.7.
F ig3 .8 . Dose—response curves fo r the ra te  of incorporation
of fro m  into fa tty  acids by acini from  m am m a ry  glands of
lactating  rats  under d ifferent physiological s ta tes .
■1.0T
2 -I'0.8—
2 -o
x ? 0.6-to 
_ O'
P Q
to
0.0
0 3 42
log [insulin] (jUU/m l)
Acini were prepared from mammary glands of normal, 
fed early-lactating rats (□) or from mid-lactating 
rats that were fed a normal (■) or cafeteria 
diet ( A )  or that were made diabetic (£0 , or starved 
for 24h (%) or starved and refed (2h) ( 0 ) .  See 
Materials and Methods chapter for experimental, 
treatments. The values shown are means (iS.E.M.) 
for the number of determinations given for the 
corresponding data in Table 3.7.
& 3.8). The concentration required to exert half 
the maximal effect was approx ima te 1 y 59jjU/m 1 for 
both total lipid synthesis and fatty acid synthesis 
(Table 3.7). This concentration is of the same 
order as that found in the plasma of the mid- 
lactating rat (19.7jjU/ml; 1.3ng/ml and 16jjl)/ml 
respec ti vel y ) (Robinson et_ aj^ . , 1978; Flint e_t a 1 . , 
1979; Burnol et. a±. , 1983).
The rate of lipogenesis observed for early lactating 
rats (two days post-partum) was about 807. of that 
observed for mid-1actating rats (Figs. 3.7 & 3.8). 
This was a higher percentage than would have been 
expected from the much lower concentrations of 
lipogenic enzymes reported previously for the stage 
of lactation in vivo at this time (Sinnett-Smith ejt 
a 1.. 1979; Martyn & Hansen, 1980; McNeillie &
Zammit, 1982). However, the overall response of 
lipogenesis to insulin for early lactating rats was 
decreased by about 25-307. (Fig. 3.9) relative to 
that for mid-1actating rats and the sensitivity of 
the tissue to insulin, as judged by the 
concentration of insulin required to elicit half- 
maximal stimulation was greater (approximate1y 
95juU/ml ) (Table 3.7) than observed for mid-1 ac tat ing 
rats. This would seem to indicate that acini from 
these rats were markedly less sensitive to insulin. 
This observation is to be expected in view of the 
lower number of insulin receptors present at this
93
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Fig.3 . 9 .
Percentage stimulation by insulin of the rate of incorporation of 
3.4 from  into total iipids by acini from  mammcny glcnds of
lactating rats under different physiologiccl stctes.
350
V)-a
CL
co♦3a
3
E
V)
X
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250-
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150 +
100
1 2 3
log [in su lin ]
The results from Fig. 3.8 were pooled together and 
expressed as percentage increases, relative to the 
control (no insulin) quoted as 100%, for each 
condition studied - normal, fed early-lactating 
rats (□), mid-lactating rats that were fed a normal 
(■) or cafeteria diet (A) or diabetic rats (&), or 
rats starved for 24h (#) or starved and refed (2h) 
(0).
stage of lactation compared to mid-1actation, though 
the affinity of the receptors is unchanged (Flint, 
1982).
3.2.2 Effects of Starvation
Starvation (24h) in mid-1actating rats resulted in a 
marked decrease in basal lipogenesis (about 80-90*/.) 
(Figs. 3.7 & 3.8) in mammary acini as has been 
observed previously ij^  vivo and in. vi t ro (Robinson & 
Williamson, 1977a; Robinson e_t aj^ . , 1978; Munday &
Williamson, 1981). Although addition of insulin to 
acini from starved rats did stimulate lipogenesis, 
it did not restore it to the rate of lipogenesis 
observed in acini from fed lactating rats. However, 
the overall percentage stimulation by insulin was 
much greater (approximately 100*/., Fig. 3.9) than 
that observed for the fed rat, although the half- 
maximal stimulation (ECStZ}) was achieved at a similar 
concentration of insulin (approximately 68jjU/ml ) 
(Table 3.7) as for fed rats, indicating that the 
starved rat is much more responsive, but not any 
more sensitive to insulin compared to the fed rat at 
the same stage of lactation.
The lack of any change in sensitivity to insulin of 
the rate of lipogenesis in mammary acini from 24h 
starved rats could be indicative of the fact that 
the decrease in the rates of lipogenesis observed is
94
not entirely due to the decreased insu1 in/g1ucagon 
concentration ratio at this time, but that some 
other factor(s) may be having an effect. Similarly, 
the fact that the rate of lipogenesis in acini from 
24h starved rats is not restored to the level of 
lipogenesis observed for fed rats by insulin 
supports the possibility that some other factor e.g. 
gastrointestina1 peptide, which would work
the full effect (Williamson ejh a\_. , 1975; Mercer &
Williamson, 1987; Page, 1989).
3.2.3 Effects of Starvation and Glucagon
Since the effect of insulin on starved lactating 
rats was markedly different from that observed for 
fed rats, it was necessary to test whether 
starvation might alter sensitivity to glucagon in 
the mammary gland. However, the incubation of acini 
from starved (24h) mid-1actating rats with glucagon 
had no effect on the rates of synthesis of total 
lipids or fatty acids (Table 3.8). Nor did glucagon 
alter the rates of lipogenesis in the presence of 
insulin (Table 3.8). Hence it would seem that rat 
mammary acini are insensitive to glucagon 
irrespective of the physiological state of the donor 
animal.
with insulin, is required to elicit
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3.2.4 Effects of Refeedinq after Starvation
Refeeding of starved mid-1actating rats for 2h 
resulted in a complete restoration of lipogenesis in 
vivo to that of the normally fed animal (Robinson ejt 
a 1 . , 1978; Robinson & Williamson, 1978; Munday &
Williamson, 1981; Mercer & Williamson, 1986). The 
changes in sensitivity of lipogenesis to insulin 
that accompany such a transition were studied. As 
the results in figs. 3.7 and 3.8 indicate, there was 
only a partial reversal by refeeding of the 
inhibition of lipogenesis indicated in acini 
isolated from starved-refed rats such that the rate 
of lipogenesis was increased to about 50'/. of that 
found for fed mid-1actating rats (Fig . 3.9). The
in vi tro was significantly increased to that for fed 
mid-1 ac tating rats (EC«,:, values: 87yuU/ml for
indicating that the sensitivity and the 
responsiveness of mammary tissue to insulin is 
impaired in the starved-refed lactating rat. The 
rapid reversal by refeeding of the metabolic effects 
of starvation on mammary tissue in_ vivo is thought 
to be indicative of enzyme activation rather than 
induction of enzymes (Robinson & Williamson, 1977a). 
It is possible that in the mammary acini 
preparations used in the experiments in Table 3.7, 
activation of a particular enzyme is not occurring
of lipogenesis to insulin in these rats
s tarved-ref ed, 59jjU/ml for fed) (Table 3.7),
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to allow the full expression of refeeding. Acetyl- 
CoA carboxylase has previously been mentioned as 
being activated by refeeding, but as previous 
experiments in Tables 3.5 & 3.6 have shown, this 
enzyme does not appear to be very responsive, nor to 
have an effect on lipogenesis under these conditions 
studied. This may be a reason why the results 
presented here do not agree entirely with earlier 
reports (Robinson et_ a_l_* i 1978; Robinson & 
Williamson, 1978; Munday & Williamson, 1981; Mercer 
& Williamson, 1986).
.5 Effects of Cafeteria Diet
Decreased rates of lipogenesis occur i_n_ vivo in the 
mammary gland of mid-1actating rats fed from 
parturition on a cafeteria diet (high fat) in 
addition to chow (Agius et a1., 1980; Brigor & 
Warren, 1980; Rolls e_t a K  , 1980; Munday &
Williamson, 1987). The basal and maximal rates of 
lipogenesis observed in the present study for acini 
from mid-1actating rats fed a cafeteria diet (plus 
chow) from day 3 of lactation were unchanged 
compared to those of mid-1actating rats fed chow 
alone (Figs. 3.7 & 3.8). However, the EC.*-, value 
for the cafeteria-fed rat ( approximate 1 y 10^U/ml ) 
was noticeably higher than the EC-*-, value for the 
mid-1actating rat (approximate1y 59uU/ml),
indicating that the sensitivity of lipogenesis in 
the cafeteria rat is reduced.
3.2.6 Effects of Long-term Insulin Defiency
Long-term insulin defiency resulting in the 
development of severe hyperg1ycaemia ( 28mM blood 
glucose as opposed to approximate1y 5mM blood 
glucose in non-diabetic rats) induced in lactating 
rats at day 3 of 1ac ta t ion by intraperitoneal 
injection of streptozotoe in (lOOmg/Kg body weight) 
resulted in a decreased rate of lipogenesis in acini 
subsequently isolated from these rats. Short- and 
long-term diabetes also results in diminished rates 
of mammary lipogenesis in_ vivo (Walters & McLean, 
1968; Baldwin & Yang, 1974; Robinson & Williamson, 
1977a; Robinson e_t a_l_. , 1978; Cowie et a_l^. , 1980) .
These observations confirm that mammary tissue is an 
insulin-responsive tissue both with respect to long 
and short-term mechanisms of the hormone (Field & 
Coore, 1976; McNeil lie & Zammit, 1982; Jones e_t 
aj_. , 1984a , b ) . Treatment of acini from long-term 
diabetic rats with insulin resulted in much larger 
fractional stimulation of lipogenesis (approx. 200’/.) 
(Fig. 3.9) than it caused in those from animals in 
other physiological states. However, as in the case 
of starvation, insulin did not restore the rate of 
lipogenesis in acini from long-term diabetic rats to 
that observed in acini from fed lactating rats.
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This lack of response in_ vitro contrasts with that 
observed when insulin is administered to short-term 
streptozotocin (3h) rats in_ vivo; such treatment 
completely restores the rate of lipogenesis 
(Bussmann ejt a_l_. , 1984). The reason for these
differences, between short-term and long-term 
diabetes in the rat, is that in long-term diabetic 
rats the total enzyme concentrations and activity of 
enzymes associated with lipogenesis are greatly 
reduced. Whereas in the short-term diabetic rat 
only the activities of the lipogenic enzymes are 
affected and hence insulin can quite easily reverse 
these effects. The sensitivity to insulin of acini 
from long-term diabetic rats was markedly increased 
relative to that for acini from normal lactating 
rats. Thus the EC.*-, (approximately 3SjjU/ml) for 
diabetic rats was in keeping with the increased 
sensitivity expected under these conditions compared 
to fed lactating rats. The observed increased
increase in the number of insulin receptors and/or 
affinity of insulin receptors which might compensate
In order to study the effect of varying degrees of 
insul in-deficiency i_n vivo on the insul in­
responsiveness of acini in_ vi tro, the effect of
to insulin could be the result of an
for the very low insulin concentration.
injecting different doses of into
mid-1actating rats on acinar lipogenesis was
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investigated. Doses of either 50mg (Group A) or 
80mg (Group B) streptozotoe in/Kg body weight were 
administered intraperitonealy on day 3 of lactation, 
and acini were isolated from these rats on day 10. 
The basal rate of lipogenesis observed in acini 
isolated from both groups of rats were similar to 
each other (Figs. 3.10 & 3.11) and to the rates 
observed for acini isolated from normal fed 
lactating rats. However, the acini isolated from 
Group B rats were more sensitive to insulin than 
those isolated from normal rats, but were less 
sensitive than acini isolated from rats treated with 
a still higher dose of streptozotocin (lOOmg/Kg body 
weight) (Table 3.9). The implications of such 
results are not clear. Possibly the doses of 
streptozotocin in Group B rats are sufficient to 
affect the sensitivity of acini to insulin by 
altering either the number or affinity of the 
insulin receptors on mammary acini, but not enough 
to impair the rate of lipogenesis in any way (Table 
3.9). The moderate degree of hypoinsu1inaemia 
achieved by Group A rats did not result in any 
significant increase in sensitivity of the rate of 
lipogenesis in acini isolated from these animals 
relative to that observed for acini from normal 
rats. Rates of lipogenesis intermediate between 
those observed for 80V. (ie 80*/. of maximally 
effective dose) streptozotocin-treated rats, or fed 
rats, and 1007. strep tozo toe in-treated rats were very
100
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mid-lactating rats that were made diabetic by 
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80mg/Kg (#) or lOOmg/Kg (A). See Materials and 
Methods chapter for experimental treatments. The 
values shown are means (iS.E.M.) for the number of 
determinations given in Table 3.9.
difficult to achieve experimentally by manipulation 
of the streptozotocin dose. Attempts to obtain 
these reproducibly were not successful.
101
CHAPTER 4
STUDY OF THE REGULATION OF ADIPOSE TISSUE LIPOLYSIS BY
GLUCAGON DURING PREGNANCY AND LACTATION
!
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During lactation, the mammary gland is the major 
site of lipogenesis despite the low absolute 
concentration of plasma insulin and of a much lower 
insulin/glucagon concentration ratio compared to 
unmated animals. One of the reasons for this may be 
the insensitivity of the mammary gland to glucagon 
(Chapter 3). In the non-1actating and especially 
the pregnant rat the major lipogenic tissue is 
adipose tissue. In the fed state, the high 
insulin/glucagon concentration ratio favours a high 
rate of lipogenesis. However, in the presence of a 
low insulin/glucagon concentration ratio (e.g. 
starvation) adipose tissue is able to readily become 
lipolytic. It supplies non-esterified fatty acids 
to other tissues primarily as substrates for energy 
formation. During lactation, the adipose tissue has 
a very low rate of lipogenesis and a high rate of 
lipolysis, favoured by the low insulin/glucagon 
concentration ratio and other hormonal changes 
including elevated prolactin and glucocorticoid 
concentration (Baldwin & Yang, 1974; Cowie et^  al . ,
1980). The rates of lipogenesis in adipose tissue 
are low during lactation. Thus direct comparisons 
to the mammary gland of the sensitivity of this 
process in this tissue to insulin and glucagon 
during lactation was not possible because of the 
practical difficulties in measuring such low rates. 
Hence it was decided to examine the sensitivity of 
glucagon to lipolysis in adipocytes isolated from
103
animals at different stages of reproduction. In 
addition the effects of starvation on this parameter 
were also studied.
In the present study, the range of concentrations of 
glucagon required to stimulate lipolysis (see below) 
were similar to, but slightly higher than, those 
required to affect the activity (Zammit & 
Corstorphine, 1982b) and the state of
phosphorylation (Holland et al_- > 1985) of acetyl-CoA 
carboxylase. However previous experiments ijn vitro 
with adipose tissue have required higher 
concentrations than the range of circulatory 
glucagon concentrations ijn vivo to elicit a 
relatively modest enhancement of the lipolytic rate 
(Vaughan, 1960; Hagen, 1961). A possible reason for 
this requirement for slightly higher concentrations 
may be the longer incubation periods involved in the 
present study to enable a measurable accumulation of 
glycerol in the medium.
4.1 EFFECT OF ADENOSINE DEAMINASE ON THE RATE OF 
LIPOLYSIS
Adenosine is released by adipocytes into the 
incubation medium ijn vi tro (Schwabe ejt a_l_. , 1973) 
and from adipose tissue in. vivo (Fredholm & Sollevi,
1981). Low concentrations of adenosine are known to 
inhibit the lipolytic effect of glucagon (Vaughan,
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1960; Hagen, 1961; Blecher et. a_K , 1969; Fernandez &
Saggerson, 1978; Saggerson, 1986; Vernon ejt a 1 . ,
1983, 1987; Zammit, 1988) through the adenosine- 
mediated inhibition of adenylate cyclase. The 
response of adipocytes to hormones that activate 
this enzyme is modified depending on the dose- 
response relationship between the particular 
metabolic activity affected and the concentration of 
adenosine in the medium. Inclusion of adenosine 
deaminase in the incubation medium of adipocytes 
lowers the concentration of adenosine hence 
relieving the inhibition of lipolysis (Schwabe et_ 
al., 1975; Fain, 1977), which can lead to enhanced 
responsiveness of triacy 1 g 1 ycero 1 hydrolysis to 
glucagon in adipocytes from male rats (Honnor & 
Saggerson, 1980; Honnor et aX. , 1985; Saggerson,
1986), to glucagon in female lactating rats (Zammit, 
1988) and to noradrenaline in female lactating rats 
(Aitchison ejt a_l_* » 1982; Vernon et. aj_» > 1987). So 
in this study, it was decided that the effect of 
glucagon on glycerol release in adipocytes from 
female rats during pregnancy and lactation would be 
measured in the absence and presence of adenosine 
deaminase.
In order to determine what concentration of 
adenosine deaminase was required to observe effects 
on lipolysis, isolated adipocytes from fed virgin 
and fed mid-lactating rats were incubated with
105
increasing concentrations of adenosine deaminase in 
the absence and presence of glucagon (10~®M).
Virgin and lactating rats were chosen because 
preliminary experiments had indicated that these had 
the lowest and highest rates of lipolysis 
respectively. The adenosine deaminase dose-response 
curve in the absence of glucagon (Figures 4.1 & 4.2) 
showed that adenosine deaminase itself, presumably 
by removing adenosine, increased basal lipolysis 
(see above). Moreover, the use of a high 
concentration (50mU/ml) of adenosine deaminase 
tended to mask the effect of increasing 
concentrations of glucagon on lipolysis (Figure 
4.3) .
A comparison of the rates of lipolysis obtained with 
and without glucagon at each concentration of 
adenosine deaminase used, revealed a greater 
enhancement of lipolysis in response to glucagon at 
low concentrations of adenosine deaminase compared 
to high concentrations of adenosine deaminase 
(Figures 4.1 & 4.2). Consequently, a concentration 
of 4mU/ml adenosine deaminase was used because it 
had a minimal effect on basal lipolysis, yet gave a 
greater amplitude of response of lipolysis to 
glucagon. The use of the same concentration of 
adenosine deaminase for experiments on adipocytes 
from starved and diabetic male rats in the presence 
of glucagon was chosen for similar reasons by Honnor
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Fig.4 . ] .  Dose response curves for the effect of adenosine 
deaminase on the rate of lipolysis in adipocytes from fed
virgin rats.
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& Saggerson, (1980). Therefore results of the 
present study and those of previous studies are 
directly comparable. However, it is appreciated 
that working at this concentration of adenosine 
deaminase, the rates of lipolysis obtained may be 
very sensitive to small differences in the amount of 
enzyme used in individual experiments. Consequently 
variability in rates was observed between different 
series of experiments although within individual 
series reproducibi1ity was good. Any variability in 
absolute rates could not, of course, affect the EC.*., 
values which are expressed relative to the maximal 
rates observed within the same experiment.
4.2 BASAL AND MAXIMALLY GLUCAGON-STIMULATED RATES OF 
LIPOLYSIS
The basal rate of glycerol release (ie no glucagon 
and no adenosine deaminase) was similar for 
adipocytes from virgin, late pregnant (P^), early- 
(Lt) , mid- (L±0) and late- (L^ ,.,) lactating rats 
whether fed or starved (Figure 4.4, Table 4.1). The 
presence of adenosine deaminase in the medium caused 
either no change or an increase in the basal rates 
(Figure 4.4, Table 4.1). The increase in the basal 
rates for starved pregnant and fed mid-lactating 
rats seem to indicate that lipolysis is more 
sensitive to the presence of adenosine at this time; 
although the variation of the basal rate of the fed
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Fig.4 .4 . Dose—response curves with respect to glucagon for the 
rate of lipolysis in adipocytes isolated from 2 0 —day 
pregnant rats.
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mid-lactating rats is very great compared to other 
basal values.
The addition of glucagon in the absence of adenosine 
deaminase to incubations of adipocytes from animals 
in all the physiological conditions studied resulted 
in a marked stimulation of glycerol release (Figure 
4.4, Table 4.1). In the fed state, the rate of 
lipolysis in adipocytes increased gradually from a 
low value observed in virgin rats to higher values 
observed in pregnancy and lactation. Although, a 
slightly lower value was obtained in adipocytes at 
one day post-partum compared to adipocytes from 
other stages of lactation (Table 4.1). 24h-
starvation resulted in an even greater increase in 
the response of the cells to glucagon (approximately 
two fold) except during early lactation when there 
was no significant change (Table 4.1).
The presence of adenosine deaminase in addition to 
glucagon in the incubation medium resulted in a 
further stimulation of lipolysis for animals in all 
conditions (Figure 4.4, Table 4.1), following the 
trend observed in the absence of adenosine deaminase 
(Table 4.1). However, as in the absence of 
adenosine deaminase, there was no significant 
difference between the rates in adipocytes of fed or 
starved early lactators. There was a three-fold 
increase in maximal response of starved virgin rats
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relative to fed virgin rats; smaller starvation- 
induced increases were observed for pregnant and 
mid-lactating rats (Table 4.1). This relatively 
small increase was due primarily to a much greater 
effect of the inclusion of adenosine deaminase on 
the lipolytic rate in adipocytes from these fed 
animals (five-fold stimulation) than in those from 
starved animals. Therefore even in the presence of 
maximally effective concentrations of glucagon the 
enhanced response of adipocytes from fed lactating 
rats to partial removal of adenosine was apparent 
(see above).
4.3 CHANGES IN SENSITIVITY OF LIPOLYTIC RATE OF GLUCAGON 
CONCENTRATION
Dose-response curves for the rate of lipolysis at 
increasing concentrations of glucagon were obtained 
for adipocytes from rats in the various 
physiological conditions studied. Experiments were 
performed in the absence or presence of adenosine 
deaminase (4mU/mI, see above). Maximal stimulation 
of lipolysis by glucagon was always obtained at 
10-"r-10-='M glucagon. A representative set of dose- 
response curves is shown in Figure 4.4. The 
concentration of glucagon required to elicit half 
this maximal response (EC-*-,) was used as an index of 
the sensitivity of the cells to glucagon. In the 
absence of adenosine deaminase the EC-*., for glucagon
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was highest in the cells from virgin rats and lowest 
in the cells from pregnant rats, with early 
lactating and mid- 1 actating rat cells displaying 
£C»c> values of intermediate values. This trend was 
observed however in cells from fed and starved 
animals (Table 4.2). However, the absolute value of 
EC-*-, for starved rats was much lower than 
corresponding values for fed rats, indicating 
increased sensitivity under these conditions.
The addition of adenosine deaminase to the medium of 
cells from fed and starved animals resulted in lower 
E C ^  values in comparison to those for adipocytes in 
the absence of adenosine deaminase with one 
exception. This was afforded by starved early- 
lactating rats that had the same EC-*., whether in the 
presence or absence of adenosine deaminase.
However, there was no change in the sensitivity of 
cells from starved rats in comparison to cells from 
fed rats in the presence of adenosine deaminase, 
except for cells from starved ear 1 y- 1 actating rats 
that showed an increased EC-*., value (Table 4.2).
Thus it can concluded that generally the presence of 
adenosine led to a greater increase in sensitivity 
to glucagon for fed animals (40-fold) than for 
starved animals (4 to 10-fold). This would seem to 
indicate that starved rats are less sensitive to the 
removal of adenosine than were fed animals, with
1 1 0
Ta
bl
e 
4.2
 
Ch
an
ge
s 
in 
se
ns
iti
vi
ty
 
(E
C
5o
) 
to 
gl
uc
ag
on
 
of 
the
 
ra
te
s 
of 
lip
ol
ys
is
 
in 
ad
ip
oc
yt
es
 
fro
m 
fe
m
al
e 
ra
ts 
in 
di
ffe
re
nt
 
st
ag
es
 
of 
the
 
re
pr
od
uc
tiv
e 
cy
cl
e.
M
ea
su
re
m
en
ts
 
we
re
 
pe
rfo
rm
ed
 
as 
de
sc
rib
ed
 
in 
the
 
M
at
er
ia
ls
 
6c 
M
et
ho
ds
 
ch
ap
te
r 
in 
the
 
pr
es
en
ce
 
or
«c 01 o 0)
0) 0) 
c © c .c c
© c
o £
« s.V
2 c 
o
> c
c o O -CCT» 0) 01
a 
o
3
©
-C
©
©
a
©
-o
©
o
n *o
o
o T?
o o 
a. 
©© c
.o a
a ©
•*-* > c o © o
O Q. 
C ^o a
T5a
^  u
© ° ^  Q.
.'tr ©■Q ©
co o
o  © **- 
C c -C n
D O
E .5
® .sn © 
o  X .
«SI
© "S
1 °^ o
© "O -Q C
“In « 
9  o
v S
CL O
'—  c
*c E © oL. ©© "O ♦—
"O c
> % ’©  
3 O c c a © 
o "O
S  °  *5o> o
i - "E ° >%O u 
© ©
■o .o
© E
C 3 
*© c
c «
^ 5 £ S  
«♦- *
I s 
I  ®■t; «
« o
© 3 O .c u
" j iJ3 -H 
O v—
O
5 ®an c 
© © 
3 © —  © O v_ 
>  Ol
2
c
o
ino
L I
co
O 'O
a
_3
o
□
-o Li
© >
*o cn
X) <o 1—
© cn
©/^-xo —
c E
c \
I ?
© E
■O tTv_/
©
c □© LIo L.
c
©■p
<
©co-3
"O-oO
Q 
LlJ 
>  a.:
£
□
laJ
rT'—" '—'
+ r-
+ o or“ <—
+< +i +i
9 9+ +m m
/■—X
+
s—■*
■+ 9 9
CM o +’
+1 +i +i
9 9 o
cd CM m’
T~
_ _
n M" +
w '—'
r- 9 9
cd +
m T“
+i +» +1
r- CM o
cd in CM
+ fO m
—U ■+ inTw ' ' w
co 9 9
CO o T~
*+ r—
+1 +\ +•
o o o
o cd o+ Ol co
CO
4J
c
a i
c cO'
l
>\
O' © v_L.
5 CL
a
Li
GO
+io
0 0
co
d
+1q
o
co
CM
+»m
rn
O l
m
+ro
+»r>#
cd
CM
cnc O'c
La
te
- 
29
.7
± 9.
6 
(3
) 
10
.9
+3
.3
 
(3
)
La
ct
at
in
g
starved ear 1 y- 1 actating rats being particularly 
insensitive to its removal.
4.4 ADIPOCYTE VOLUME DURING PREGNANCY AND LACTATION
The adipocyte mean cell volume (MCV) of fed rats 
fell significantly from 434±72pl at 20 days of 
pregnancy to 131±30pl at 20 days lactation (Figure 
4.5). The values obtained for rat adipocyte MCV are 
in agreement with those previously reported 
(Aitchison et_ a_l_. , 1982) except for the value of 
virgin rats. The reason for this difference is not 
known. The effects of 24h starvation on parametrial 
adipocyte volume in virgin, pregnant and lactating 
rats are shown in Figure 4.5. Mean cell volume was 
decreased by starvation in all groups of animals, 
although statistical significance was achieved only 
in the case of adipocytes from 2 0 -day pregnant 
animals (p<0.05 starved versus fed; Student's t- 
test) which had undergone a net lipid mobilisation 
equivalent to 125pl per adipocyte (difference 
between fed and starved mean cell volume) after 24h 
starvation. In marked contrast, starvation-induced 
lipid mobilisation from adipocytes of early 
lactation animals was minimal (13pl per adipocyte) 
although net lipid mobilisation tended to rise in 
mid-lactating animals (30pl/cell). Starvation of 
weight-matched virgin animals resulted in a volume 
loss of 36pl per adipocyte. This pattern of lipid
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Fig.4.5. Effects of pregnanacy and lactation on the mecn adipocyte 
volume in parametrial adipose tissue of fed and starved rats.
500 j
{ O— O fed rats
100 -I— NN— I-- 1--1— y'f'— I---- 1
V 20 P 1 10 20
Dcys pregnont Doys loctotinq
Adipocyte cells were obtained and measured as 
described in Materials and Methods chapter. Mean 
adipocyte cell volume was measured for parametrial 
adipose tissue from virgin rats (V), late pregnant 
rats (20 days pregnant), early-lactating rats 
(1 day lactating), mid-lactating rats (10 days 
lactating) and late-lactating (20 days lactating) 
in fed or starved animals. Values are means 
+ 5 .E.M. for the number of determinations shown in 
parentheses.
mobilisation after starvation of animals at 
different stages of pregnancy and lactation is 
broadly consistent with that of the changes in 
sensitivities to glucagon and the absolute rates of 
lipolysis in^  vi tro of adipocytes for corresponding 
categories of starved animals (see Table 4.2). 
Conversely, there appears to be little 
correspondence between glucagon sensitivities of 
adipocytes from fed animals throughout pregnancy and 
lactation and the decline in adipocyte volume in 
vivo accompanying their starvation for 24h.
4.5 DISCUSSION
There are not many reports to which the results 
presented in this chapter can be compared to 
directly. Previous work measuring rates of 
lipolysis in pregnant and lactating rats, compared 
to virgin rats, have been either performed in 
adipose tissue slices (Knopp e_t a_l_. , 1970; Smith & 
Walsh, 1976; Farid e_t al_. , 1978; Gillon, 1981), or 
else in adipocytes during various stages of 
pregnancy and lactation, but using different 
lipolytic hormones eg noradrenaline, adrenaline, 
cor t icotrophin, to enhance lipolysis (Aitchison e^ t 
al_. , 1982; Vernon et_ aj_. > 1983, 1987). A subsequent 
study, prompted by the experiments reported here 
(Zammit, 1988), does provide a more direct 
comparison to the work reported above. However, the
1 1 2
concentration of adenosine deaminase (1 Unit/ml) 
used by Zammit (1988) is much greater, resulting in 
an insignificant amount of adenosine being present 
in the incubation medium, and the concentration of 
glucagon (25nM) used to elicit a maximal response of 
lipolysis in the presence of lU/ml adenosine 
deaminase is much lower (Zammit, 1988) compared to 
the concentrations of glucagon used in Figure 4.4, 
Table 4.1. Also the rates of lipolysis in response 
to glucagon in adipocytes from starved rats could 
only be measured in the presence of a maximally 
anti-1ipolytic dose of insulin (Zammit, 1988). The 
results expressed in Table 4.1 agree with the 
results of Zammit (1988) in that adipocytes from 
mid- 1 actating rats in both studies have the highest 
maximal rates of lipolysis in the presence of 
glucagon in fed and 24h-starved rats, but the rates 
of lipolysis for the other conditions studied were 
different. The sensitivity of lipolysis to glucagon 
(Table 4.2) in adipocytes from rats at different 
stages of the reproductive cycle, whether fed or 
starved, are of a different order of magnitude to 
those expressed by Zammit (1988), and indicate that 
in the fed and starved state that late-pregnant 
animals are the most sensitive to glucagon (Table 
4 .2 ) in contrast to late-pregnant animals being the 
least sensitive to glucagon in the fed animal 
(Zammit, 1988). The reasons for these differences 
between the two studies is most likely to be due to
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the differing amounts of adenosine deaminase used, 
and therefore the amount of adenosine present within 
the incubation medium.
The rates of lipolysis obtained for experiments 
presented in this chapter are generally in agreement 
with what one might expect. Namely, that the rates 
of lipolysis are generally increased during late 
pregnancy and lactation compared to the virgin 
state. One apparent anomaly would appear to be 
early-lactating rats, which had low absolute rates 
of lipolysis and low sensitivity to glucagon. These 
properties, if reflected iji vivo would result in 
minimal rates of triacylglycerol mobilisation from 
adipose tissue of ear 1 y- 1 actating animals both in 
the fed and in the 24h-starved states. These 
observations can be rationalised in terms of the low 
requirement for exogenous substrates by the mammary 
gland at a time when lactation is not yet 
established.
In mid-lactating rats both the absolute rates of 
lipolysis and the sensitivity to glucagon are much 
higher. These observations agree with the generally 
accepted view that preformed fatty acids released 
from adipose tissue supplement de novo synthesis of 
fatty acids in the mammary gland (see Zammit, 1985). 
This suggests that glucagon may have an important 
role in effecting the direction of substrates
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towards the gland during lactation. The lipolytic 
rates obtained for adipocytes from pregnant animals 
were most interesting and they demonstrate the 
potential role of glucagon at this time. In these 
cells half-maximal rates of lipolysis were obtained 
at glucagon concentrations that were of an order of 
magnitude lower than those required by cells from 
animals in other physiological conditions studied. 
These observations suggest that during starvation 
adipose tissue of pregnant rats is likely to respond 
by mobilising triacylglycerols at a greater rate 
than adipose tissue of rats at other stages of the 
reproductive cycle. Changes in the rates of 
lipolysis in response to starvation in. vivo are 
regulated by a variety of factors, not least by 
changes in the molar concentration ratio of glucagon 
(lipolytic) to insulin (anti1ipolytic). The present 
observations suggest that changes in E C ^  values for 
glucagon may form a significant part of the adaptive 
increase in adipose tissue lipolysis that occurs 
during starvation especially in late pregnant 
animals. Such an enhanced response could account 
for the increased susceptibility of late pregnant 
animals to the development of ketonaemia, because 
the increased release of fatty acids from adipose 
tissue would furnish additional substrate for 
hepatic ketogenesis, while concomitant changes in 
the liver would facilitate their use for oxidation 
(Zammit, 1980, 1981; Zammit & Corstorphine, 1982a).
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The accumulation of adenosine in the medium of 
adipocytes seemed to have a greater effect on 
adipocytes from fed rats than starved rats for all 
physiological conditions studied, with exception of 
ear 1 y - 1 ac ta t ing rats. I_n_ vi vo , adenosine acts as a 
vasodilator in adipose tissue (Sollevi & Fredholm, 
1981), thereby affecting the rate of fatty acid 
release into the blood stream (Scow, 1965), yet at 
the same time, adenosine is also rapidly metabolised 
and removed by the blood (Fredholm & Sollevi, 1981). 
Therefore the build up of adenosine observed in 
vi tro would not occur to the same extent in_ vi vo.
The conditions created for the experiments presented 
in this chapter i.e. the removal of some, but not 
all adenosine by adenosine deaminase, may well 
approximate to conditions in_ vivo. The reasons for 
the differences between adipocytes from fed and 
starved rats is not clear. It is possible that 
there is an increased rate of adenosine production 
in fed rats compared to starved rats, or fed rats 
may not be able to metabolise adenosine as well as 
starved rats due to an increase in the sensitivity 
of fed rats to adenosine, or a combination of these 
effects may occur. It has been suggested (Vernon et 
al., 1983) that adenosine has a role regulating the
rate of lipolysis to ensure that the stores of 
triacylg 1 ycero 1 do not become depleted too rapidly, 
especially during lactation when lipid reserves are 
low compared to pregnancy. Adenosine may have a
116
similar role to play for fed and starved rats; a 
greater rate of lipolysis being required during 
starvation to meet the needs of the rat at that time 
than in the fed animal.
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CHAPTER 5
GENERAL DISCUSSION
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The significance of the findings for the regulation of 
substrate utilization for lipogenesis in mammary gland 
and adipose tissues during pregnancy and lactation are 
discussed in this chapter.
The major finding of the results presented in chapter 3 
was that glucagon had an effect on adipose tissue but not 
on mammary gland during lactation. Glucagon did not 
inhibit lipogenesis in rat mammary acini, nor did 
glucagon reverse the stimulatory effect of insulin on 
lipogenesis in the rat mammary acini. The lack of effect 
of glucagon on mammary gland was primarily due to the 
fact that there were no receptors for glucagon on the rat 
mammary gland. The significance of this finding is that 
the mammary gland will only be responsive to the 
concentration of plasma insulin, not the insulin/glucagon 
concentration ratio. Whereas adipose tissue is dependent 
on the insulin/glucagon concentration ratio as it is 
responsive to both insulin and glucagon. This also means 
that the actions of insulin in the mammary gland cannot 
be antagonised by glucagon, nor can glucagon enhance the 
effects of other inhibitory hormones. Hence the 
difference in responsiveness of mammary and adipose cell 
preparations in. vitro to glucagon suggest that the two 
tissues may be differentially responsive to changes in 
the circulating insulin/glucagon concentration ratio in 
vivo during lactation.
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Insulin had a stimulatory effect on lipogenesis in 
adipose tissue and mammary gland, but at different times 
during the reproductive cycle. During pregnancy, adipose 
tissue lipogenesis is increased relative to lipogenesis 
in the tissue in the virgin rat (Vernon & Flint, 1983). 
This is due to a high insulin/glucagon concentration 
ratio (Saudek ejt al_. , 1975) and increased insulin
receptor numbers (Flint et. aX* * 1979). At the onset of
lactation, the rate of lipogenesis observed in adipose 
tissue decreases to a very low level and the 
concentration of lipogenic enzymes in adipose tissue is 
greatly reduced (Smith, 1973; Robinson e_t al_. , 1978;
Agius et_ al_. , 1979; Flint e_t al_- > 1979; Sinnett-Smith e_t 
al . , 1980; Burnol ejt a_l_* > 1983, 1986a,b, 1987; Jones et 
a1, 1984a). The insulin/glucagon concentration ratio 
drops to a level lower than that observed in virgin rats 
(Robinson et. a_l_* > 1978; Flint et al_> 1979), which in 
itself is unfavourable for lipogenesis in the adipose 
tissue. This is also accompanied by a decrease in the 
number of insulin receptors on adipose tissue to a level 
similar to that observed in the virgin rat, but lower 
than the level observed in the pregnant rat (Flint et 
a1., 1979; Flint, 1980). This implies that despite the 
normal level of insulin receptors relative to the virgin 
rat, adipose tissue must also have a reduced sensitivity 
to insulin (Kilgour & Vernon, 1988; Zammit, 1988). The 
mammary gland on the other hand has a high rate of 
lipogenesis at this time despite the low insulin/glucagon 
ratio (Robinson et aj_* » 1978). The number of insulin
1 2 0
receptors on the mammary gland increase from late 
pregnancy (day 2 0 ) to mid- 1 actation (day 1 0 ), with the 
greatest increase occurring between late lactation and 
early lactation (day 2 ), but with no change in affinity 
of the receptors at this time (Flint, 1982). However, by 
mid- 1 actation the sensitivity of the receptors has also 
increased (Flint, 1982). The increased numbers and 
affinity of the insulin receptors on the mammary gland 
ensure that the stimulatory effects of insulin on the 
mammary gland metabolism are promoted despite the low 
plasma insulin concentration.
In the virgin rat, adipose tissue is capable of 
lipogenesis and lipolysis depending on the nutritional 
and physiological status of the animal and the 
insulin/glucagon concentration ratio. Insulin and 
glucagon act antagonistically to each other in adipose 
tissue. Lipogenesis is stimulated by insulin and 
inhibited by glucagon, hence very small changes in the 
plasma insu 1 in/g 1 ucagon concentration can determine the 
rate of lipogenesis in adipose tissue. Lipolysis is 
regulated in a similar way and is just as sensitive to 
changes in the insulin/glucagon ratio, except that 
insulin inhibits lipolysis and glucagon stimulates 
lipolysis. So that during pregnancy when the 
insulin/glucagon ratio is high and adipose tissue has 
increased sensitivity to insulin, high rates of 
lipogenesis are observed, but the rates of lipolysis are 
low because of the high levels of insulin and its
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inhibitory effects on lipolysis (Knopp ejt al_. > 1973;
Flint et a1. , 1979; Naismith et a 1. , 1982) . Conversely,
during lactation when the insu 1 in/g 1 ucagon concentration 
ratio is low, and adipose tissue has decreased 
sensitivity to insulin, rates of lipolysis are high 
partly due to the levels of glucagon in the plasma, but 
also due to the low levels of insulin (Vernon e_t a 1 ,
1983, 1987; Kilgour & Vernon, 1988; Zammit, 1988).
The results in chapter 4 demonstrated the sensitivity of 
lipolysis in adipose tissue to glucagon through pregnancy 
and lactation. Lipolysis in adipocytes from late 
pregnant rats reflected the changes starting to occur in 
the mother in preparation for parturition and the onset 
of lactation. There was a switch from low rates of 
lipolysis to high rates of lipolysis which was also 
accompanied by an increased sensitivity to glucagon 
relative to that observed in the virgin rat. During 
early lactation, when lactation is not yet fully 
established, lipolysis rates dropped to a low level which 
was accompanied by a decrease in sensitivity to glucagon 
as there is not the demand from the mammary gland for 
triacylglycerols at this stage of lactation. However as 
lactation progressed, the rates of lipolysis and the 
sensitivity of adipose tissue to glucagon increased as 
the demand for preformed fatty acids increased. The 
changes in response of adipose tissue lipolysis to 
glucagon appeared to facilitate the mobilization of fatty 
acids from adipose tissue either for the energy demands
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of the mother (especially in pregnancy) and/or for the 
substrate demands of the mammary gland when lactation was 
fully established. By contrast, during early lactation 
adipose tissue became refractory to glucagon action. It 
is suggested that this represents part of a general 
adaptation that enables the sparing of stored 
triacylglycerol in spite of the large decrease in insulin 
concentrations from the high levels observed during 
pregnancy (Saudek et al_- > 1975) to the low concentrations 
that occur during early lactation (Robinson et_ a_l_-> 1978; 
Flint et. §lL* > 1979). The decreased effectiveness of 
glucagon on adipose tissue would counteract the 
diminution of the anti 1 ipo 1 ytic effects of insulin.
The sensitivity to insulin of lipogenesis in the mammary 
gland varied throughout lactation with low rates of 
lipogenesis and sensitivities being observed during early 
lactation, increasing to high rates of lipogenesis and 
sensitivity at mid- 1 actation as might be expected as 
lactation progressed and the demand for milk increased 
(Robinson et al_. , 1978). Nutritional effects on the 
rates of lipogenesis during lactation were investigated.
A high energy diet (cafeteria diet) did not result in 
decreased rates of lipogenesis as reported before in this 
tissue (Agius et a 1., 1980; Rolls et a1., 1980), but
maintained the rates of lipogenesis observed in the acini 
from rats fed a normal diet (chow only). However acini 
from rats fed a cafeteria diet did have decreased 
sensitivity to insulin. 24h starvation resulted in
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decreased rates of lipogenesis and an increased 
sensitivity to insulin indicating that starvation 
conserves energy at this time, but also primes the tissue 
to be responsive to increases in insulin that would occur 
on refeeding. As might be expected, refeeding from 
starvation does indeed increase the rate of lipogenesis, 
but not to the levels observed prior to starvation 
implying that some other factor is required to permit the 
normal levels of lipogenesis to be met. Diabetic rats 
had very low rates of lipogenesis as a result of the very 
low plasma insulin concentration similar to the effect 
observed for starved animals. However, acini from these 
rats were most sensitive and responsive to insulin. 
Although, the addition of insulin did not return the 
rates of lipogenesis to the level observed in fed rats as 
mammary gland acini from diabetic rats do not have the 
capability to achieve such rates due to low levels of 
lipogenic enzymes present at this time.
The various changes in enzyme activities in adipose 
tissue and mammary gland, and their differing 
sensitivities of each tissue to insulin and glucagon, 
explain how these two tissues work together in a 
complementary way. Thus, when demand for milk is high 
e.g. during mid-lactation, the elevated rates of 
lipogenesis in the mammary gland can be maintained, with 
adipose tissue lipolysis supplementing de novo fatty acid 
s y n t h e s i s -  __Conversely , when demand for mammary g land _  
fatty acids is low e.g. early lactation, lower rates of
124
mammary gland lipogenesis and adipose tissue lipolysis 
are observed.
The points raised in the discussion suggest that there 
are important physiological implications for the 
reciprocal regulation of the rates of lipogenesis in 
adipose tissue and mammary gland in the lactating rat. 
For a tissue that is sensitive to the insu1in/g1ucagon 
ratio (such as adipose tissue) the hormone-sensitive 
steps of the lipogenic pathway will be relatively 
inhibited, whereas in a tissue that is not sensitive to 
glucagon (mammary gland) the activity of the lipogenic 
pathway would not be markedly affected. Hence the 
differential responsiveness of the two tissues to 
circulatory insulin during lactation would be achieved.
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